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Abstract
The Immune Inhibitor A1 protease of Bacillus anthracis
Publication No. _____________
Kathryn J. Pflughoeft
Supervisory Professor: Theresa M. Koehler, Ph.D.

Bacillus anthracis, an organism ubiquitous in the soil and the causative agent of
anthrax, utilizes multiple mechanisms to regulate secreted factors; one example is the
activity of secreted proteases. One of the most abundant proteins in the culture supernates
of B. anthracis is the Immune Inhibitor A1 (InhA1) protease. Here, I demonstrate that
InhA1 modulates the abundance of approximately half of the proteins secreted into the
culture supernates, including substrates that are known to contribute to the ability of the
organism to cause virulence. For example, InhA1 cleaves the anthrax toxin proteins, PA,
LF, and EF.

InhA1 also targets a number of additional proteases, including Npr599,

contributing to a complex proteolytic regulatory cascade with far-reaching affects on the
secretome. Using an intra-tracheal mouse model of infection, I found that an inhA-null
strain is attenuated in relation to the parent strain. The data indicate that reduced virulence
of the inhA mutant strain may be the result of toxin protein deregulation, decreased
association with macrophages, and/or the inability to degrade host antimicrobial peptides.
Given the significant modulation of the secretome by InhA1, it is likely that
expression of the protease is tightly regulated. To test this I examined inhA1 transcript and
protein levels in the parent and various isogenic mutant strains and found that InhA1
expression is regulated by several mechanisms. First, the steady state levels of inhA1
transcript are controlled by the regulatory protein SinR, which inhibits inhA1 expression.
Second, InhA1 abundance is inversely proportional to the SinR-regulated protease
camelysin, indicating the post-transcriptional regulation of InhA1 by camelysin. Third,
InhA1 activity is dependent on a conserved zinc binding motif, suggesting that zinc
availability regulates InhA1 activity. The convergence of these regulatory mechanisms
signifies the importance of tight regulation of InhA1 activity, activity that substantially
affects how B. anthracis interacts with its environment.
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Chapter I
Introduction
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1.1. History
Bacillus anthracis and the associated anthrax disease have a rich history in infectious
diseases research. Anthrax and its symptoms, black lesions and blood, were first described
and named 2,500 years ago by Hippocrates. B. anthracis was the first bacterium to be
linked to a disease by C.J. Davaine nearly 150 years ago, work that was later validated by
Robert Koch (129). B. anthracis served as the basis for Koch’s postulates, and Louis
Pasteur used the organism in his early vaccine work (129, 149). The transmission of B.
anthracis is primarily a problem in developing nations, with the vaccination of livestock in
the western world reducing the morbidity and mortality of B. anthracis infections (129,
149). The potential use of B. anthracis as a biological weapon has spurred additional
interest in the molecular and physiological characterization of this organism. Programs
studying the weaponization of B. anthracis were initiated during World War I and have
continued in the subsequent decades. Fears that the organism would be used as an agent of
terrorism were realized in 2001 (129).
1.2. Physiology, growth, and lifecycle
B. anthracis is a versatile organism that can adapt to a changing environment by
drastically altering its cell morphology. The Gram-positive rod-shaped bacilli forms spores
upon nutrient starvation. The vegetative form of the bacterium is a large bacillus 3-10 µm in
length and 1-1.5 µm in width (139). Growing bacilli are often found in long chains that can
tangle to form knots or clumps in liquid culture (84) (unpublished data). The colony
morphology of B. anthracis is dependent upon growth condition and can appear either dry
with irregular edges or mucoid in the presence of capsule (84). The cell envelope is
composed of the membrane, a thick layer of peptidoglycan that constitutes the cell wall, a
layer of the cell-wall-associated proteins, Sap and Eag which has been termed the S-layer,
and a proteinacious capsule (50). The spore form of the bacterium, which is resistant to
extreme temperature, desiccation, and other environmental challenges, appears as a light
refractile elongated sphere of 1-2 µm in diameter (139). Spore proteins belong to one of
four main structures that are built out from the chromosome-containing core at the center of
the spore, the cortex, the coat, and the exosporium (37). As not all species of Bacillus
possess an exosporium the function of the outermost structure of the spore is not well
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defined. The other spore structures are conserved among Bacillus species and function to
protect the chromosome until nutrients are available allowing for germination and outgrowth
to vegetative cells (37).
In the absence of germination signals, B. anthracis can retain dormancy as a spore
for extended periods of time. Upon germination the vegetative form of the bacterium
readily grows and replicates in a wide array of environments. In the laboratory, optimal
growth conditions for B. anthracis are nutrient rich media with aeration at 37ºC, however
the bacterium can grow in media that contains a variety of carbon sources and at
temperatures ≤43ºC (84). In the natural environment, the vegetative form of the bacilli can
survive in the rhizosphere (126); however the spore appears to be the dominant form in the
soil. Low germination frequencies (up to 2%) have been reported for B. anthracis spores in
soil (72).
While the cell can complete its lifecycle from spore to vegetative cell to spore within
the soil or laboratory media, the lifecycle of B. anthracis often encompasses both in vitro
and in vivo environments. This cycle begins with dormant spores gaining entry into a host.
The spores then germinate, and proliferation of the vegetative cells leads to disease and host
death. Upon decay of the host, nutrients are depleted forcing the bacilli to sporulate,
returning spores to the soil.
1.3. Taxonomy
Much of what is known regarding the basic physiology of B. anthracis has been
inferred from studies performed on the archetype species Bacillus subtilis. Despite much
overlap, detailed research into several conserved pathways has outlined important
phenotypic differences between these species (119, 155) (Chapter IV of this work). B.
anthracis is a member of the Bacillus cereus group of closely related organisms, which
includes Bacillus cereus, Bacillus thuringiensis, and B. anthracis. Members of the B. cereus
group have highly conserved chromosomal gene content and synteny, and are thought to
have a common origin (117). The B. anthracis genome consists of a 5.2-Mb circular
chromosome and two large circular plasmids, pXO1 (181.7-kb, including genes encoding
the toxin proteins) and pXO2 (94.8-kb, including capsule biosynthetic genes) (118).
Traditionally, one feature that distinguishes B. anthracis from other B. cereus group
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members is the presence of the virulence plasmids pXO1 and pXO2. However, recent
findings indicate that at least one strain of B. cereus harbors a plasmid with similar gene
content to pXO1 (68).
1.4. Anthrax disease and models of infection
B. anthracis is primarily a non-human pathogen, and most anthrax disease occurs in
land-grazing animals, however humans are susceptible to the disease. With respect to
human cases of anthrax there are three different forms of the disease, each of which are
based upon the route of infection, cutaneous (the most common), inhalational (highest
lethality rate), and gastrointestinal. For each route of infection the infectious form of the
organism is the spore (139). The working model for inhalational anthrax is that the infection
can be broken down into three stages: association of spores with phagocytes, spore
germination, and dissemination of toxin- and capsule-expressing vegetative cells (139) (Fig.
1-1). Much remains to be determined with regard to disease progression, including the role
of immune cells, the timing of germination, and the relative contribution of putative B.
anthracis virulence factors.
As anthrax is a zoonotic disease many animals are susceptible to infection with B.
anthracis and have been employed as models to study the progression of anthrax disease.
Classically, rabbits and guinea pigs have been used to model human disease and in vaccine
development as they have comparable immune systems to that of humans (57). However,
mice are often utilized to study infection as they are highly susceptible to infection with B.
anthracis as well as the effects of anthrax toxin (57). Differences in the infectivity of
various mouse strains by B. anthracis and routes of infection have been well documented
(97) allowing for the efficient use of mice in the study of anthrax disease.
1.5. Virulence factors
B. anthracis produces two classic virulence factors, a poly-D-glutamic acid capsule
and a tripartite toxin (139), as well as several putative virulence factors including a number
of secreted proteases and the cytolysin anthrolysin O. Similar to the capsule of many other
pathogenic bacteria, the B. anthracis capsule is anti-phagocytic, prolonging the survival of
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Figure 1–1. Model of the progression of inhalational anthrax. Spores enter the lung
where they are transported to the regional lymph nodes by alveolar macrophages. Upon
germination, vegetative cells multiply and disseminate throughout the body causing
septicemia as depicted in the high numbers of bacilli in the blood and cerebral spinal fluid of
the infected host.
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bacilli within the host (42). Depolymerization of capsule enhances phagocytosis and killing
of B. anthracis vegetative cells (130).
The B. anthracis tripartite AB toxin consists of two individual A (active or
enzymatic) moiety toxin proteins, edema factor (EF) and lethal factor (LF), and the B
(binding) moiety protective antigen (PA) (30). PA binds to the host-cell anthrax toxin
receptors (ANTXR1 and ANTXR2), and is processed by a host protease, leading to
association between host-cell-bound PA and EF and/or LF (6, 9, 66, 153). Upon association
of EF and/or LF with PA, the active toxins are translocated into the host cell. Once
intracellular, EF and LF interfere with host-cell-signaling through distinct well-defined
mechanisms (110). LF inhibits necessary components of host signal transduction pathways
by cleaving mitogen-activated protein kinases (MAPKs) (19, 66, 110, 120). EF increases
the concentration of intracellular cAMP, reducing the activity of the host-cell-signaling
factors Mek 1 / 2 and ERK, and ultimately causing edema at the site of infection (66, 110).
1.6. Contribution of secreted proteases to bacterial virulence
Bacteria secrete proteases as a means to modify their environment, leading to
enhanced survival and virulence.

With respect to Gram-negative and Gram-positive

pathogens the secretion of proteases to serve as virulence factors has been well documented
(64). Despite extensive study of secreted proteases in other pathogens little is known
regarding the secreted proteases of B. anthracis. A classic example of a secreted protease
that contributes to virulence is the SpeB protease produced by the human pathogen
Streptococcus pyogenes. SpeB has a wide range of substrates, including proteins produced
by the host, such as IgG and extracellular matrix (ECM) proteins, and proteins produced by
the bacterium, including the cell-wall-anchored M protein and the secreted protein C5a
peptidase (107, 156).
Additional examples of virulence-enhancing secreted proteases are the HA protease
of Vibrio cholerae, the SspA, SspB, and Aur, proteases of Staphylococcus aureus, and the
Rgp protease of Porphyromonas gingivalis. The V. cholerae HA protease both directly and
indirectly effects virulence by processing host proteins and activating cholera toxin (10, 64).
In addition to processing bacterial and host proteins, such as ClfB and the heavy chain of
human immunoglobulin, the S. aureus SspA, SspB, and Aur proteases form a proteolytic
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cascade whereby each protease activates the zymogen form of the subsequent protease
(134). Such a proteolytic cascade represents a highly regulated mechanism of protein
modification that can impact the extent and timing of protease activity. The P. gingivalis
Rgp protease alters the N-terminus of two filamentous surface proteins involved in the
virulence of the organism, the 75-kDa protein and fimbrilin.

Following secretion and

cleavage of the signal sequence, Rgp processes the fimbrilin and the 75-kDa protein prior to
assembly of the mature filaments, such that rgp mutant strains are deficient in filament
formation (76, 135).
Secreted proteases can also indirectly affect the virulence of a bacterium by
modulating the secretory system. The MycP1 protease of Mycobacterium tuberculosis
cleaves the EspB protein, a necessary component of the ESX-1 secretory system, such that
deletion of the protease-encoding gene results in a non-functional secretory apparatus (108).
Similarly, some but not all effectors secreted by autotransporters are released from the outer
membrane of Gram-negative bacteria by designated proteases. An example of this is the
adhesion protein App that is cleaved by the NalP protease of Neisseria meningitidis,
releasing the active form of App from the cell (34).
1.7. Secreted proteases of B. anthracis
Although extracellular proteases have been demonstrated to play substantial roles in
the virulence of many pathogens, few of the proteases secreted by B. anthracis have been
implicated as contributing to the virulence of the organism. The most studied protease
secreted by B. anthracis is the anthrax toxin component LF. LF is a zinc metalloprotease
that has limited targets in the host, cleaving the Mek3/6, Mek 4/7, and Mek 1/2 MAPKs
which in turn modulates host signaling pathways (43, 103).
The protease Immune Inhibitor A1 (InhA1) has also been implicated in enhancing B.
anthracis virulence, through the cleavage of an array of substrates. In work carried out by
Popov and co-workers, InhA1 was purified and characterized as a neutral zinc
metalloprotease (28). Subsequently, InhA1 was found to cleave ECM proteins, including
fibronectin and type I and type IV collagen using in vitro protease assays (28). In similar
experiments, purified InhA1 was demonstrated to cleave proteins involved in the host
coagulation cascade, including fibrinogen, plasmin inhibitors, and prothrombin (28, 79). The
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InhA1-mediated cleavage of prothrombin results in the active thrombin protein (79).
Moreover, in ex vivo experiments examining clot formation, human blood incubated with
the inhA1 mutant strain had a clotting time that was prolonged compared to blood incubated
with the parent strain (79).

Finally, InhA1 also appears to modulate levels of a host

fibrinolysis regulatory protein, Plasminogen Activator Inhibitor (PAI-1), as mice injected
with purified InhA1 have elevated PAI-1 transcript and protein levels (26). Taken together
these data suggest that InhA1 modulates the coagulation cascade in the host, potentially
impacting dissemination of B. anthracis in the blood.
Several additional proteases secreted by B. anthracis have predicted roles in
pathogenesis (3, 28, 114). For example, Neutral Protease (NprB or Npr599) has been
posited to contribute to B. anthracis virulence, as it cleaves laminin and fibronectin (28).
The sheer abundance of Npr599 in culture supernatant alludes to a potentially significant
role for the protease in B. anthracis survival in the host or environment. Npr599 and InhA1
together account for between 80%-90% of the B. anthracis secretome when the organism is
grown to stationary phase in Nutrient Broth Yeast extract (NBY) (22). The secreted protein
chaperone, HtrA, and the cell-wall hydrolase NlpC/P60, both of which have proteolytic
activity, are detected in high levels in the plasma of infected animals (131). In addition to
freely secreted proteases, B. anthracis also expresses cell-associated proteases, such as
camelysin (59). An orthologue of camelysin produced by B. thuringiensis was found to
cleave the B. thuringiensis toxin protein Cyt2Ba (106). Whether camelysin, or indeed any
protease other than LF, contributes to the virulence of B. anthracis remains to be assessed.
1.8. Regulation of the B. anthracis secretome
While knowledge of host signaling molecules that induce B. anthracis virulence
factor expression is limited, virulence factor expression is regulated by the pleiotropic
virulence gene regulator AtxA when cultured in media containing sodium bicarbonate and
incubated at elevated CO2 (51, 84). Under such “toxin-inducing” conditions the most
abundant protein in the B. anthracis secretome is the anthrax toxin protein PA. Interestingly,
while InhA1 and Npr599 are the predominate proteins in the culture supernates in the
absence of toxin-inducing conditions, in the presence of toxin-inducing conditions, Npr599
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levels are below the level of detection in the supernatant, while InhA1 accounts for between
two and five percent of the secretome late in stationary phase of growth (22).
Additional B. anthracis proteins that are prominent in the culture supernatant include
the S-layer protein Sap and an array of enzymes with proteolytic activity. Sap is a cell-wallassociated protein whose abundance in culture supernates is strain and growth condition
dependent (22, 90). B. anthracis secretes at least 14 different proteases, the abundance of
which are largely growth-condition dependent (22). Many of the proteins secreted in vitro
are also produced in vivo and are immunogenic, reacting with antibodies produced by B.
anthracis-infected animals (23).
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Chapter II
MATERIALS AND METHODS
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2.1. Strains and culture conditions. B. anthracis strains and plasmids are described in
Table 2-1.

The virulent Ames strain (pXO1+, pXO2+), attenuated Sterne strain 7702

(pXO1+, pXO2-), and mutants derived from these strains were used in this study, unless
otherwise noted. Escherichia coli strain TG-1 was used as a host for cloning. E. coli strain
GM2163 (dam- dcm-) was used to generate a source of unmethylated plasmid DNA. E. coli
strain Rosetta pLysS was used for protein expression. Unless noted otherwise, B. anthracis
strains were cultured at 37ºC with shaking (200 rpm) in Luria-Bertani (LB) medium with
0.5% glycerol for RNA and protein isolation, or in Nutrient Broth Yeast (NBY) medium for
optimal InhA1 protein secretion. E. coli strains were cultured in LB at 37ºC with shaking
(200 rpm). Antibiotics were added as appropriate: Kanamycin (100µg/ml), Spectinomycin
(100µg/ml for B. anthracis and 50µg/ml for E. coli), Erythromycin (5µg/ml for B. anthracis
and 150µg/ml for E. coli), Carbenicillin (100µg/ml), and Chloramphenicol (34µg/ml).
2.2. DNA isolation and manipulation. Cloning experiments employing E. coli were
performed using standard protocols (4). Plasmid DNA was extracted from E. coli using the
Wizard

Miniprep

kit

(Promega,

Madison,

WI)

following

the

manufacturer’s

recommendations. Unmethylated plasmid DNA from E. coli strain GM2163 was used for
electroporation of B. anthracis (85).

DNA was amplified using PCR using Phusion

Polymerase (New England Biolabs, Ipswich, MA) unless otherwise noted. Oligonucleotide
primers are described in Table 2-2. PCR products were purified using the Qiagen gel
purification kit (Qiagen, Valencia, CA). Restriction enzymes were purchased from New
England Biolabs. T4 DNA Ligase was purchased from Promega. Chromosomal DNA was
extracted from B. anthracis using the Mo Bio genomic isolation kit (Mo Bio Laboratories,
Solana Beach, CA).
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Table 2-1. Strains and Plasmids used in this study
a, b

Strain or Plasmid
Strains
Ames
UTA21
UTA5
UTA13
UTA7
7702
UT315
UT345
UT356
UT365
UT371
UT222
UT317
UT368
UT379
UT381
UT382
UT385
UT282
UT284
UT306
UM23c1-2 ∆secA
UT357

Virulent strain, pX01 and pX02
sinR- null mutant, derivative of Ames
r
UT222 transduced with CP51 propagated on Ames; inhA1 -null mutant, Spc
r
UT324 transduced with CP51 propagated on Ames; npr599 -null mutant , Kan
r
r
UT282 transduced with CP51 propagated on UTA5; inhA1 inhA2 -null mutant, Spc , Kan
+
Sterne strain, pX01
r
sinR -null mutant, derivative of 7702, Spc
inhA1 -null mutant derivative of 7702
r
calY -null mutant derivative of 7702, Spc
sinI -null mutant derivative of 7702
sinI sinR- null double mutant derivative of 7702
r
inhA1 -null mutant derivative of 7702, Spec
r
npr599 -null mutant derivative of 7702, Kan
inhA1 point mutant H374A derivative of 7702
inhA1 point mutant H374D/E375A derivative of 7702
inhA1 point mutant E375A derivative of 7702
inhA1 point mutant E374A/H378D derivative of 7702
inhA1 point mutant H378D derivative of 7702
r
inhA2 -null mutant derivative of 7702, Kan
r
r
inhA1/inhA2 -null mutant derivative of 7702, Kan Spc
r
r
inhA2
plcR
UT282 derivative,
gene integrated into the
locus, Kan Spc
r
secA -null derivative of UM23c1-2, Kan
r
r
UT356 transduced with CP51 propagated on UM23c1-2 ∆secA ; calY- null mutant, Kan , Spc

Plasmids
pUTE583
pHY304
pET23d
pUTE964
pUTE1011
pUTE973
pUTE980

Vector used for allelic exchange, Erm
r
Vector used for markerless deletion, temperature sensitive, Erm
r
IPTG-inducible expression vector, Ap
pET28b, SinR N'terminal His-tag
pET28b, npr599 minus signal sequence C'terminal His-tag
r
r
IPTG-inducible expression vector with hyperspank promoter, Kan , Amp
pUT973 containing inducible calY

a
b

Characteristic

Source or Reference
+

+

r

Ravel et al 2009
This study
This study
This study
This study
Guidi-Rontani et al 2001
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
Collin Harwood
This study

Chen et al 2004
Chaffin et al 2005
Novagen
This study
This study
This study
This study

null mutants were created by allelic exchange (Spcr) or markerless mutants
Spcr - spectinomycin resistant, Kanr - Kanamycin resistant, Ermr - Erythromycin resistant
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Table 2-2. Primers used in this study
Primers used in this study
a
Sequence
Name
GTCGACCAACGCCAGCTTTTTCGGC
KP95
GGATCCCAGACTGGCCACCCGCTCC
KP96
GGATCCGGGTGTACCGAAGTTTGATG
KP93
GTCGACGTAAGCGGCGTCAGCTGTTTCG
KP94
GTCGACGCTGGCTTCCATATAGTAAAAG
KP116
GGATCCCCTAATTTCTTTTTCAGAC
KP117
GGATCCCCAAGAAGCTGGAGAAG
KP118
CTCGAGCATAGAGGGAGTTTAATGG
KP119
GTCGACGTGTTGTATTTATATAGGTATG
KP79
GGATCCCTTGAATTTACAAAATGGAAG
KP80
GGATCCCGTTTTATACGTTCTCCAATC
KP81
GAATTCGTTTAAACGTTTCGATTTTAC
KP82
JR109
GAGAGAGCACTATCACTCACC
JR110
GGTGCGCAAATTAATAGAAAGAAGTGCTTACAAACC
JR111
CACTTCTTTCTATTAATTTGCGCACCTTTCTATCAATATG
JR112
GCGTACAATGGTGATGTACG
JR107
AGGTATGGGAGTTGCATCAG
JR108
AGGGAGGAATTACATGTTTGTTCTTTTTAACGAAGTTTATG
JR105
CGTTAAAAAGAACAAACATGTAATTCCTCCCTAATTATCAATC
JR106
CAGTTCCTGGTAAAGCTG
JR114
GGGAGGAATTACATTAATAGAAAGAAGTGCTTACAAACC
JR113
CTTCTTTCTATTAATGTAATTCCTCCCTAATTATCAATC
GCCGTCGACCAGCTGTATTAGGCCTTTCATTC
KP138
KP139
CTAAATCATGACCATATTCAGCTGCGAATACACCGACCGC
KP140
GCGGTCGGTGTATTCGCAGCTGAATATGGTCATGATTTAG
GCCTCTAGAGCATAGTTTCTCCACTCAAC
KP141
GCGGTCGGTGTATTCGCAGATGCATATGGTCATGATTTAG
KP162
CTAAATCATGACCATATGCATCTGCGAATACACCGACCGC
KP163
GTATTCGCACATGCATATGGTGATGATTTAGGTTTAC
KP170
GTAAACCTAAATCATCACCATATGCATGTGCGAATAC
KP171
CACATGAATATGGTGCTGATTTAGGTTTACCAGATG
KP172
KP173
CATCTGGTAAACCTAAATCAGCACCATATTCATGTG
GTCGACCAACGCCAGCTTTTTCGGC
KP95
GGATCCCAGACTGGCCACCCGCTCC
KP96
GGATCCGGGTGTACCGAAGTTTGATG
KP93
GTCGACGTAAGCGGCGTCAGCTGTTTCG
KP94
GGATCCGAAGTAGCAGCAGTTAAGC
KP71
CTGCAGCGTTTGGTGTTTTTTAAG
KP72
GTCGACGGGATATTGCTACACTTGAAGAAG
KP73
GGATCCAACAATATCAGGTTTACTGC
KP74
ATGAGCTCGGGGAAAAGGGTGGATTAGA
ES27
ATGGATCCGGTGTTCCTGTTGCAGGTTT
ES28
ATGGATCCGAAGGGACACAATTCAAA
ES29
ATGGTACCTCGCAATGCCTCGATTAACT
ES30
GTCGACGCTGGAGTAACGACAAATCCA
KP03
GGATCCAAGTGGCGCTTTTCTTCTCA
KP08
GGATCCCAAGTTGTTGGACAGGCAGA
KP09
CTGCAGGGATAATTCCATCATTGTC
KP10
KP192
biotin-GTGATATACTCGTATGCTAAC
KP193
GTTTCTTGTTCATCCCTTATTTC
KP79
biotin-GTGTTGTATTTATATAGGTATG
KP117
CCTAATTTCTTTTTCAGAC
nprF
biotin-ACCGGAAAGGGGTTTTTCAATATTTG
nprR
GAAAAAGAGTAGTTTCATATTAG
sipWF
biotin-TAACTAATAATTGTAAATTTTCTTATTGC
sipWR
TCTCCGTTGTTTTATATTATTTG
b
KP111
CCATGGATTCTAAAAATGTGCTGTCTAC
CTCGAGGTTTACGCCAACAGCAC
KP112
GGGCTAGCATGATTGGAGAACGTATAAAAC
KP168
GGCTCGAGTTATTTTTGATTTTGCTTCC
KP169
GGGTCGACCAGCTAGGGGGAATTGATTG
KP183
GGGCATGCGTGCTTACAAACCGCACTTC
KP184
a
b

Function
inhA1 markerless mutation
inhA1 markerless mutation
inhA1 markerless mutation
inhA1 markerless mutation
calY allelic exchange
calY allelic exchange
calY allelic exchange
calY allelic exchange
sinR allelic exchange
sinR allelic exchange
sinR allelic exchange
sinR allelic exchange
sinR and sinIR markerless mutation
sinR markerless mutation
sinR markerless mutation
sinR markerless mutation
sinI markerless mutation
sinI markerless mutation
sinI markerless mutation
sinI and sinIR markerless mutation
sinIR markerless mutation
sinIR markerless mutation
inhA1 point mutants
inhA1 point mutant H374A
inhA1 point mutant H374A
inhA1 point mutants
inhA1 point mutant H374D/E375A
inhA1 point mutant H374D/E375A
inhA1 point mutant E375A and E374A/H378D
inhA1 point mutant E375A and E374A/H378D
inhA1 point mutant H378D
inhA1 point mutant H378D
inhA1 markerless mutation
inhA1 markerless mutation
inhA1 markerless mutation
inhA1 markerless mutation
npr599 allelic exchange
npr599 allelic exchange
npr599 allelic exchange
npr599 allelic exchange
inhA1 allelic exchange
inhA1 allelic exchange
inhA1 allelic exchange
inhA1 allelic exchange
inhA2 allelic exchange
inhA2 allelic exchange
inhA2 allelic exchange
inhA2 allelic exchange
inhA1 EMSA probe
inhA1 EMSA probe
calY EMSA probe
calY EMSA probe
npr599 EMSA probe
npr599 EMSA probe
sipW EMSA probe
sipW EMSA probe
npr599 expression
npr599 expression
sinR expression
sinR expression
calY expression
calY expression

underline indicates a restriction site
Lysine codon optimized for expression in E. coli (CTC to CTG)
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2.3. Construction of B. anthracis mutants. B. anthracis null strains were constructed as
allelic exchange mutants or as markerless gene deletion mutants. Allelic exchange mutants,
in which specific DNA sequences were replaced with a Ω-spectinomycin or Ω-Kanamycin
resistant cassette, were constructed using pUTE583 as described previously (20).
Transductants were created as previously described (67). All mutations were verified with
PCR and DNA sequencing.
Markerless mutations were created using pHY304, a temperature-sensitive vector
harboring an erythromycin-resistance gene (16).

DNA fragments corresponding to

approximately 1-kb sequences upstream and downstream of the locus to be deleted were
cloned in tandem into pHY304. The DNA inserts for the deletion constructs were generated
using PCR using EasyA Taq (Stratagene, La Jolla, CA) to amplify upstream and
downstream sequences separately, or using overlap extension (SOE) PCR to amplify a
single DNA fragment deleted for the gene of interest (70). To obtain a markerless mutant,
the specific pHY304 construct was introduced into B. anthracis using electroporation (127).
The electroporation mixture was plated on LB medium containing erythromycin and
incubated at 30ºC for two days to select isolates containing the plasmid. Clones were
verified using PCR using Taq Polymerase (NEB, Ipswich, MA), re-streaked on selective
medium, and incubated at 30ºC. A single colony was used to inoculate LB broth containing
erythromycin and the culture was incubated at 30ºC for 16 h. To obtain an isolate in which
the pHY304-derivative had integrated into the chromosome using single cross-over
recombination, the culture was passaged at a 1:100 dilution into LB containing erythromycin
and cultured at 41ºC (the non-permissive temperature for pHY304) for 10 to 14 h.
Following a second passage at a 1:1000 dilution in the same conditions, the culture was
streaked onto selective LB plates and incubated at 41ºC for 10 h. To promote excision of
the pHY304-derivative from the B. anthracis chromosome, a single colony of a clone
harboring an integrated plasmid was inoculated into LB without antibiotic, cultured at 30ºC
until turbid, and then passaged at a 1:100 dilution multiple times in LB. Starting with
passage 3, excision of the pHY304-derivative was assessed by plating serial dilutions of the
culture on LB agar and incubating at 30ºC for 16 h. Single colonies were patched to LB
agar with and without erythromycin and incubated at 37ºC for 16 h. Erythromycin-sensitive
isolates were screened for loss of the plasmid and deletion of specific sequences using PCR
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using Taq Polymerase (NEB, Ipswich, MA) and primers corresponding to DNA sequences
flanking the locus.

Point mutants were created using SOE and pHY304 for gene

replacement.
2.4. RNA purification. For transcriptional profiling experiments approximately 1x106
spores were inoculated into 25ml of LB medium and cultures were incubated until midexponential (OD600 = 0.5-0.6) or early stationary (OD600 = 3.5-3.9) growth phase. For qRTPCR cultures 25ml of NBY was inoculated with vegetative cells at an OD600 = 0.07 and
were incubated until exponential (OD600 = 0.3-0.45), transition (OD600 = 1.8-2.5), early
stationary (OD600 = 3.7-5.0), or stationary (OD600 = 4.4-7.4) growth phase. Six-ml samples
were taken at exponential phase and 2ml samples were collected at stationary phase. Cells
were pelleted at 2,400 x g for 10 min at 4°C. All subsequent centrifugation steps were at
16,000 x g, 4ºC and samples were kept on ice except where noted. All but 500µl of culture
supernate was decanted. Cells were resuspended and transferred to a 1.5-ml screwcap tube
containing 500µl of 0.1-mm Zirconia/Silica beads (BioSpec Products, Bartlesville, OK) and
500µl of acid phenol warmed to 65ºC (Sigma Aldrich, St. Louis, MO). The cell suspension
was subjected to bead beating for 1 min using a Mini BeadBeater (BioSpec Products,
Bartlesville, OK). The tube was placed at 65ºC for 5 min, and the bead-beating was
repeated. Following centrifugation for 3 min, the aqueous phase was transferred to a new 2ml tube. Acid phenol (500µl) was added and the tube was held at room temperature (RT)
for 5 min followed by vigorous shaking for 15 sec. Following centrifugation for 3 min, the
aqueous phase was transferred to a new 2-ml tube, 0.3 volumes of chloroform was added,
and the contents were shaken vigorously for 15 sec. The suspension was incubated for 10
min at RT, inverting frequently to avoid separation of phases. Following centrifugation, the
aqueous phase was mixed with 250µl of diethylpyrocarbonate-treated water and 500µl of
isopropanol. After incubation at room temperature for 10 min, RNA was pelleted using
centrifugation for 15 min.

Pellets were washed in 75% cold ethanol, air dried, and

resuspended in 50µl of diethylpyrocarbonate-treated water.

Final concentrations of

extracted RNA ranged from 700-3,400ng/µl, as determined using a Nanodrop ND-1000
(Nanodrop Technologies, Wilmington, DE). 20µg of RNA was DNase-treated three times
using Turbo DNA-free (Ambion, Austin, Tx) according to the specifications of the supplier,
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and the quality and quantity of RNA was assessed using a Bioanalyzer 2100 system (Agilent
Technologies, Santa Clara, CA). RNA was stored at -80ºC.
2.5. Transcriptional profiling. A custom Affymetrix (Affymetrix Inc., Santa Clara, CA)
microarray containing 16 antisense oligonucleotide probe pairs for each gene in the Ames
ancestor genome was used for microarray experiments (111). RNA samples were isolated
from three independent cultures of each of the strains analyzed (parent and sinR mutant) per
time point (exponential and stationary phase), giving 12 samples total. cDNA was created
from 5.6µg of each RNA sample using random primers and Superscript III according to the
manufacturers protocol (Invitrogen, Carlsbad, CA). Following cDNA synthesis, RNA was
removed by NaOH hydrolysis, and the cDNA purified by phenol/chloroform extraction
followed by ethanol precipitation. 8µg of each cDNA sample was fragmented using DNase
I (Promega), biotin-labeled using the Affymetrix genechip labeling reagent (Affymetrix,
Santa Clara, CA) and TDT (Promega), and hybridized to the microarray (one array per
cDNA sample).

After overnight incubation with rotation (40°C, 60 rpm), the twelve

microarrays were washed and scanned using standard Affymetrix protocols. This research
was performed in collaboration with Paul Sumby at the Methodist Hospital Research
Institute in Houston, TX.
Gene expression estimates were calculated using Gene Chip Operating System
(GCOS) v1.4 (Affymetrix, Santa Clara, CA), and data were normalized across samples. The
data were transferred from GCOS into EXCEL and analyzed using three independent
methods. For manual analysis, EXCEL was used to subtract background (signal intensities
of <50), the signal for each gene was averaged across the three replicates per strain per time
point, and the fold-change (parent/sinR mutant) was determined. Two programs, Arraystar
(DNAstar, Madison, WI) and dCHIP (Wing Wong and Cheng Li Labs, Harvard, Cambridge,
MA) were used to confirm differential gene expression. For the Arraystar analysis, raw data
were imported from EXCEL and fold-change was determined for each gene, with those
greater than two-fold being reported. Similarly, for dCHIP analysis, raw data were imported
from EXCEL, a background signal of 100 was subtracted, fold-change was determined, and
genes with a fold-change of greater than 1.5 were reported. The raw data were deposited at
the MIAME compliant Gene Expression Omnibus (GEO) database at the National Center
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for Biotechnology Information (http://www.ncbi.nlm.nih.gov/geo) and are accessible
through accession number GSE22559.
Changes in gene expression of sipW (GBAA1287), tasA (GBAA1288), calY
(GBAA1290), and GBAA_pX02_0023 were confirmed using semi-quantitative RT-PCR.
PCR reactions used gene specific primers, cDNA made as described above, RNA controls,
or DNA controls (41). The 16S gene amplified from cDNA was used as a loading control.
Changes in inhA1 (GBAA1295) were confirmed using quantitative RT-PCR.
2.6. Quantitative RT-PCR.

Specific quantitative assays for inhA1 and inhA2 were

developed using Beacon Designer, AlleleID (Premier Biosoft), or RealTimeDesign
(Biosearch Technologies) software based on the Bacillus anthracis Ames strain sequence
from NCBI. Real-time qPCR assay information is provided in Table 2-3.
“cDNA was synthesized in 5µl total volume by the addition of 3 µl/well RT
master mix consisting of: 400 nM assay-specific reverse primer, 500µM
deoxynucleotides, Superscript II buffer and 1 U/µl Superscript II reverse
transcriptase (Invitrogen, Carlsbad, CA), to a 96-well plate (ISC Bioexpress,
Kaysville, UT) and followed by a 2µl volume of sample (25 ng/µl). Each
sample was assayed in triplicate plus a control without reverse transcriptase to
access DNA contamination levels. Each plate also contained an assay-specific
sDNA (synthetic amplicon oligo) standard spanning a 5-log template
concentration range and a no template PCR control. Each plate was covered
with Biofilm A (Bio-Rad, Hercules, CA) and incubated in a PTC-100
thermocycler (Bio-Rad, Hercules, CA) for 30 min at 50°C followed by 72˚C for
10 min. PCR master mix, 15 µl/well, was added directly to the 5µl RT volume.
Final concentrations for the PCR were 400 nM forward and reverse primers
(IDT, Coralville, IA), 100nM fluorogenic probe (Biosearch Technologies,
Novato, CA), 5mM MgCl2, and 200µM deoxynucleotides, PCR buffer, 150nM
SuperROX dye (Biosearch Technologies, Novato, CA) and 0.25U JumpStart
Taq polymerase per reaction (Invitrogen, Carlsbad, CA). RT master mixes and
all RNA samples and DNA oligo standards were pipetted using a Tecan Genesis
RSP 100 robotic workstation (Tecan US, Research Triangle Park, NC); PCR
master mixes were pipetted utilizing a Biomek 2000 robotic workstation
(Beckman, Fullerton, CA). Each assembled plate was covered with optically
clear film (Applied Biosystems, Foster City, CA) and run in a 7900 real-time
instrument using the following cycling conditions: 95°C, 1 min; followed by 40
cycles of 95°C, 12 sec and 60°C, 30 sec. Data were analyzed using SDS 2.3
(7900) software (Applied Biosystems, Foster City, CA) with FAM reporter and
ROX as the reference dye. Synthetic, polyacrylamide gel electrophoresis
(PAGE) -purified DNA oligos used as standards (sDNA) encompassed at least
the entire 5’ – 3’ amplicon for the assay (Sigma-Genosys, The Woodlands, TX).
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Table 2-3. qRT-PCR primers and probes used in this study
Sequence
(and nucleotide in relation to start codon (and strand))
Name
gyrB F
ACTTGAAGGACTAGAAGCAG (54(+))
gyrB R
GTCCTTTTCCACTTGTAGATC (121(-))
gyrB probe CGAAAACGCCCTGGTATGTATA-BHQ1 (76(+))
TATAGCGGTCATGGTGAACCAG (1168(+))
inhA1 F
GAGAAACTTGTTGGCGTCGTTC (1262(-))
inhA1 R
inhA1 probe TTTACCTGCCCAGCTTCCGCCGC-BHQ1 (1233(-))
inhA2 F
ATAGCTTTAAAGATAACTGGGTTG (2036(+))
inhA2 R
GCTTCTGGATGAGAGTCTACA (2111(-))
inhA2 probe CAAGGAATCCTTCACCTGGATGCACC-BHQ1 (2086(-))

Accession
number
NC_003995
NC_003995
NC_003995
NC_003997
NC_003997
NC_003997
AE026879
AE026879
AE026879

PCR
Limit of Length of
Efficiency detection product
(%)
(copies) (bases)
98%
218
67
98%
218
67
98%
218
67
97%
154
95
97%
154
95
97%
154
95
95%
187
78
95%
187
78
95%
187
78
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Each oligo standard was diluted in 100 ng/µl E. coli tRNA-H2O (Roche
Diagnostics, Indianapolis, IN) and spanned a 5-log range in 10-fold decrements
starting at 0.8 pg/reaction. Due to the inherent inaccuracies in quantifying total
RNA using absorbance, the amount of RNA added to an RT-PCR from each
sample was more accurately determined by measuring the amount of at least
one transcript that was invariant across all samples.”
Methods for quantitative RT-PCR were communicated by Gregory Shipley at the University
of Texas, Health Science Center, Houston.

Final data were normalized to the previously-

used housekeeping gene gyrB (41). This research was performed in collaboration with
Gregory Shipley at the University of Texas, Health Science Center, Houston.
2.7. Coomassie and Western blot analysis. To assess cell-associated and freely-secreted
protein levels, 2ml culture samples were centrifuged at 6,000 x g for 5 min. Cell pellets were
stored at -20ºC until ready for use, at which time they were thawed on ice and resuspended
in 75µl resuspension buffer (50mM Tris, 3mM sodium azide, pH 7.6) and 75µl 2x SDS
loading buffer (25% 0.5M Tris pH 6.8, 2.5% SDS, 20% glycerol, 0.05% β-mercaptoethanol,
0.02% Bromo Blue).
Culture supernates were filtered through a 0.22-µM filter (Nalgene, Rochester, NY).
To assess proteases in the supernatant, proteins were precipitated using deoxycholate and
trichloroacetic acid (21) at 0.01% and 15%, respectively, and incubated on ice for 30 min or
stored at -20ºC overnight. Frozen supernatant samples were thawed on ice and precipitated
protein was pelleted at 16,000 x g for 20 min at 4ºC.

Protein pellets were washed with 1ml

of cold acetone at -20 ºC, and incubated on ice for 10 min. Precipitated protein was then
pelleted as above. The acetone was removed, and pellets were air-dried for 5 min before
resuspending in 50µl of resuspension buffer and 50µl of 2x SDS loading buffer. To assess
toxin proteins in the supernatant, culture supernatant samples were filtered and prepared by
mixing supernatant in a 1:1 ratio with 2x SDS loading buffer.
Peptides from InhA1, Npr599, and camelysin that were chosen as antigens for
antisera production were predicted as surface exposed amino acids by Genscript
(Piscataway, NJ).

α-InhA1, α-Npr599, and α-camelysin antibodies against peptides

LPDKDIKTIDPAFG, EYYDNRNPDWEIGEC, and TLADLQKTDPDLLA, respectively,
were generated in rabbits, in collaboration with Genscript (Piscataway, NJ). α-InhA1, α-
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Npr599, and α-camelysin antisera was purified using Pierce Nab Spin Columns as per
manufacturers instructions (Thermo Scientific, Rockford, IL).

α-TasA (raised against

purified TasA from B. subtilis) was a gift from Adam Driks (Loyola University). Protective
Antigen, Lethal Factor, and Edema Factor poly-clonal antibodies were obtained from the
John Collier Laboratory (Harvard Medical School). SodA-1 antibodies were obtained from
BEI Resources (ATCC, Manassas, VA).
Samples derived from culture supernates and cell pellets were subjected to SDSPAGE. Gel-imbedded proteins were stained with Coomassie Blue (G-250) or transferred to
a nitrocellulose membrane using a semi-dry blotter at 300 mAmps for 20 min using Towbin
buffer (3.94g Tris base, 14.4g Glycine, and 20% Methanol) prior to Western hybridization
analysis.

Membranes were blocked in TBS-T (20mM Tris base, 137mM NaCl, 0.1%

Tween 20 [pH 7.6]) with 3% BSA for 1 h at RT prior to exposure to primary antibody for 1
h. α-InhA1, α-Npr599, α-LF, α-EF and α-Camelysin antisera were used at a concentration
of 1:1,000 in TBS-T, unless otherwise noted; α-TasA and α-PA antibody was used at
1:5,000; and α-SodA-1 was used in a 1:50,000 dilution in TBS-T. Membranes were rinsed
in TBS-T three times for 5 min each, and then exposed to HRP-conjugated goat α-rabbit
antibody (Bio-Rad, Hercules, CA) at a concentration of 1:100,000 for 1 h at RT.
Membranes were rinsed as above, developed using the Pierce SuperSignal West
Dura Extended Duration Substrate (Thermo Scientific, Rockford, IL), and exposed to
chemiluminescent light for detection.
2.8. Secretome analysis using 2D gels. B. anthracis strains 7702 and UT345 were cultured
for optimal InhA1 production in a 30ml volume. Cells were pelleted at 2,400 x g for 10 min
at 4ºC. The culture supernatant was concentrated ~50x using a centrifugal concentrator,
Centricon-15, with a 30-kDa size exclusion (Millipore, Billerica, MA).

Protein

concentration was assessed using the Pierce BSA assay (Thermo Fisher Scientific,
Rockford, IL) as described by the manufacturer in 20µl volume. Optical density of samples
was assessed using a Nanodrop ND-1000 (Nanodrop Technologies, Wilmington, DE). The
protein was TCA precipitated (as described above) omitting resuspension of the protein.
Protein pellets were shipped to Applied Biomics for analysis using Differential In Gel
Electrophoresis (DIGE). DIGE involves the Cy3-labeling of one population of proteins (e.g.
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from the parental strain), the Cy5-labeling of a second group of proteins (e.g. from the
inhA1-null strain), and the mixing and separation of both protein sets on the same gel via
2D-gel electrophoresis to enable quantification of relative protein abundance on a
secretome-wide scale. Protein spots were quantified using the software DeCyder 2D version
6.5 (GE Healthcare, Piscataway, NJ). Gel plugs were picked and returned for identification.
This research was performed in collaboration with David Engler at the Methodist Hospital
Research Institute in Houston, TX.
2.9. Mass Spectrometry. Samples were processed for peptide and protein identification via
tandem mass spectrometry and subsequent database search essentially as previously
described (60), with some modifications. Briefly, 2D gel spots were subjected to manual ingel trypsin digestion and peptide recovery, followed by analysis of resulting tryptic peptides
using MALDI-MS/MS on a Synapt HDMS mass spectrometer (Waters, Milford, MA)
operated in the data-dependent acquisition mode. Protein Lynx Global Server (PLGS v2.4;
Waters, Milford, MA) was used as the search engine to search the MS and MS/MS data
against an extracted B. anthracis Ames ancestor database from NCBI (NCBI release v175.0;
containing 11,152 protein entries for B. anthracis Ames ancestor).
To assess the purity of our purified InhA1 sample (see below) we used LC/MSE.
The purified InhA1 sample was subjected to in-solution trypsin digestion, and the resulting
tryptic peptides were chromatographically separated over a 75µm id C-18 column on a
Waters NanoAcquity UPLC (Waters, Milford, MA). Separated peptides were introduced
via nanoelectrospray ionization into the Synapt mass spectrometer (Waters, Milford, MA).
Peptide analysis was carried out with the mass spectrometer operating in the dataindependent (MSE) mode of operation, taking advantage of the parallel fragmentation
capabilities of the Synapt instrument. Peptide identification via database search was carried
out as described above using the PLGS software. This research was performed in
collaboration with David Engler at the Methodist Hospital Research Institute in Houston,
TX.
2.10. Amino-Terminal Sequencing.

Proteins were separated using SDS-PAGE and

transferred to PVDS membrane using a semi-dry blotter at 300V for 1 h in Towbin buffer.
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Protein bands were stained with R-Coomassie blue, destained, and cut from the membrane.
The N-terminal sequences of the proteins were sequenced using Applied Biosystems Procise
cLC Sequencing system (Model 492cLC, Life Technologies, Carlsbad, CA) in collaboration
with Richard G. Cook at the Baylor College of Medicine Protein Chemistry Core facility.
2.11. Purification of recombinant B. anthracis SinR. Recombinant SinR protein (rSinR)
was purified from E. coli using a protocol modified from Kearns et al. (80). Briefly, DNA
containing the sinR coding sequence was amplified using PCR using primers KP168 and
KP169. The PCR product was cloned into the NheI and XhoI restriction sites of expression
vector pET28b (Novagen, Gibbstown, NJ) to create an inducible gene encoding a thrombincleavable amino-terminal His-tagged SinR protein.

The plasmid, pUTE964, was

transformed into the E. coli Rosetta strain expressing pLysS and grown in 600ml of LB
broth to an OD600 of approximately 0.8. IPTG (1mM final concentration) was added and
incubation continued for 3 h. Cells were pelleted using centrifugation (10 min at 1,370 x g),
resuspended in 10.8ml of lysis buffer (20mM Tris, 2mM EDTA, pH 8.0), and frozen at 80ºC. Following three cycles of freeze/thaw, cell debris was pelleted at 16,000 x g at 4ºC
for 20 min. The supernatant fraction was mixed with 1ml of NTA-Ni Agarose beads
(Qiagen) rotating at 4ºC for 1 h, and unbound protein was removed from the beads in five
washes (5X bed volume each) with wash buffer (50mM Tris HCl, 500mM NaCl, and 20mM
imidazole, pH 8.5). Beads were pelleted at 1,370 x g for 5 min. The NTA-Ni agarose beads
and associated protein were resuspended in 1ml of elution buffer (10mM Tris HCl, 10mM
MgCl2, 1mM EDTA, 0.3mM DTT, 5% glycerol, 1mM PMSF, pH 8.5), and bound protein
was released from the beads using biotinylated thrombin (4.2µl; Novagen, Gibbstown, NJ)
in a 16 h reaction rotating at RT. The protein slurry was loaded on a column and rSinR and
Thombin were eluted using gravity-flow. Biotinylated thrombin was removed from the
rSinR using absorption to streptavidin-agarose beads in a 1 h reaction rotating at RT.
Thrombin-bound beads were pelleted at 16,000 x g at 4ºC for 20 min and supernatant
containing rSinR was removed. Purified rSinR was dialyzed overnight at 4ºC in 10mM Tris
HCl containing 50mM NaCl, 1mM EDTA, 5% glycerol, and 1mM DTT at pH 8.5. Protein
purity was assessed following 12% SDS-PAGE and Coomassie Blue staining. Protein
concentration was determined using OD280 and protein was stored at -80ºC.
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2.12. Purification of InhA1. The InhA1 protease was purified from the supernatant of B.
anthracis strain UM23C1-2 ∆secA/calY (UT357) cultured in 1 L of NBY medium, divided
into two 2-L bevelled flasks at 37ºC with shaking for 14 hours. The culture was centrifuged
at 2,400 x g for 10 min at 4ºC. The resulting culture supernatant was filtered through a 0.22µM PES filtration devise (Nalgene, Rochester, NY) and concentrated approximately 50-fold
using a centrifugal concentrator, Centricon-70, with a 30-kDa size exclusion (Millipore,
Billerica, MA) and dialyzed against buffer A containing 50 mM Tris-HCl (pH 7.6), 50 mM
NaCl, and 3 mM sodium azide at 4ºC. After passing through a 0.22 µM SFCA filter
(Nalgene, Rochester, NY), the protein sample was loaded onto a HiTrap Q HP column (GE
Healthcare, Piscataway, NJ) equilibrated with 20 mM Tris-HCl (pH 8) and 50 mM NaCl.
The column was washed with the same buffer and proteins were eluted with a linear gradient
of 50 mM to 1M NaCl in 20 mM Tris (pH 8) using an AKTA Purifier system (GE
Healthcare, Piscataway, NJ). Eluted proteins were analyzed using SDS-PAGE. Gels were
stained with Coomassie or proteins were transferred to nitrocellulose for Western
hybridization using antibodies specific to InhA1. Fractions determined to contain InhA1
(eluted at 228-304 mM NaCl) were combined and further concentrated to approximately to
~ 1ml at a concentration of 4.6 mg/ml using an Amicon Ultra-15 centrifugation filter
(Millipore, Billerica, MA) with a 30kDa cut-off. Purity was assessed using LC/MSE as
described above. This work was performed in collaboration with Hye Jeong Yeo at the
University of Houston.
2.13. Purification of rNpr599. npr599 (GBAA0599) was amplified using PCR using
KP111 and KP112 and was cloned into the into the NcoI and XhoI restriction sites of
expression vector pET23d (Novagen, Gibbstown, NJ), generating a C-terminal His-tagged
protein. The rNpr599 was subsequently expressed and purified from E. coli using affinity
purification to NTA resin (Qiagen, Valencia, CA). Unbound protein was washed from the
resin with 50mM NaH2PO4, 300mM NaCl, 50mM Imidazol at pH 8. Bound protein was
subsequently eluted with 50mM NaH2PO4, 300mM NaCl, 250mM Imidazol at pH 8. The
purity of the eluted protein was assessed using Coomassie staining and Western blot analysis
with Npr599-specific antibodies.
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2.14. In vitro protease assays. Purified InhA1 was mixed with substrate (rPA, rEF, rLF,
rNpr599, or rSodA-1) in protease buffer (50mM Tris, 100mM NaCl, 1mM CaCl2, 1mM
MgSO4, pH 7.8) and incubated at 37ºC for set time points. Reactions were then placed on
ice and EDTA added to a final concentration of 50mM to stop the reaction. 2X SDS-buffer
was added, samples were boiled for 5 min, separated using SDS-PAGE, and analyzed using
Western blot with substrate-specific antibodies. rPA, rLF, and rSodA-1 from B. anthracis
were obtained from BEI Resources (ATCC, Manassas, VA). rEF was obtained from List
Biological Laboratories (List Biological Labaoratories, Campbell, CA ).

rNpr599 was

purified as described above.
2.15. Electrophoretic mobility shift assays.

Electrophoretic mobility shift assays

(EMSAs) were performed using the Pierce Light Shift EMSA kit (Thermo Fisher Scientific,
Rockford, IL). Biotinylated DNA probes used in these studies corresponded to the promoter
regions of three genes implicated as SinR targets in microarray experiments, sipW, calY, and
inhA1, npr599. Probes were generated using PCR using biotinylated primers (Table 2-2) and
purified using the Qiagen gel purification kit. Probe (0.1nM) and 2µg of poly (dI-dC) were
added to reaction buffer (10mM Tris, 50mM KCl, 1mM Dithiothreitol, 0.1% NP-40, and
20mM MgCl2, pH 7.5). Five reactions were set-up for each probe tested, with one reaction
receiving no rSinR protein, and the remaining four reactions containing increasing
concentrations of rSinR protein (0.4, 2.0, 10, and 50nM). Samples were incubated at 37ºC
for 35 min and then electrophoresed in a TBE gel containing 5% bis-acrylamide at RT for 1
h at 100V. DNA was transferred from the gels to nitrile membranes using a semi-dry
apparatus (280 mA for 13 min). Following cross-linking of the DNA to the membrane using
a UV cross-linker (UVC500, GE Healthcare, Piscataway, NJ), membranes were blocked,
washed, and developed according to the Pierce Light Shift EMSA kit protocol (Thermo
Fisher Scientific, Rockford, IL).
2.16.

IPTG-inducible

expression

of

camelysin

in

B.

anthracis.

Plasmid

pdr111Hyperspank (12) containing the IPTG-inducible promoter Phyperspank, was modified as
follows for use in B. anthracis. The ori1030 from pHT304 (36) was cloned in the BamHI
restriction site. The spectinomycin resistance gene was replaced with an Omega cassette
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carrying a kanamycin-resistance gene, by digesting the vector with EcoRI and SacII, and
inserting ΩKan, creating pUTE973 (Table 1). The calY gene, carrying its native ribosomal
binding site, was amplified from B. anthracis genomic DNA with primers KP183 and
KP184 (Table 2-2), and cloned into the SalI and SphI restriction sites of pUTE973 such that
transcription of the calY gene was driven by the IPTG-inducible promoter. The calY
expression vector was named pUTE980 (Table 2-1). Camelysin and InhA1 levels produced
by each strain were assessed using Western blot analysis. Where indicated, densitometry
was utilized to quantify the signal intensity of protein bands.
2.17. India ink exclusion assay. Capsule levels were assessed using an india ink exclusion
assay as previously described (41).

Briefly, cells were cultured in NBY with sodium

bicarbonate and 5% CO2 to the exponential phase of growth and mixed on a microscope
slide with india ink. Samples were then examined under 100X microscopy using a Nikon
Eclipse TE2000-U microscope (Nikon, Melville, NY). Images were taken using Metamorph
(Imaging Series 6.1) software (Molecular Devices, Sunnyvale, CA). Capsule expression is a
reflection of the size of the halo of ink particles excluded from the bacilli.
2.18. Heat resistance assays. Suspensions of B. anthracis cells were incubated at 65ºC for
90 min. Serial dilutions of cell suspensions were plated on LB plates +/- heat treatment and
incubated overnight at 37ºC and colony forming units (CFUs) were enumerated.

The

percentage of heat resistant spores was determined by the formula: (number of CFUs after
heat treatment / number of CFUs before heat treatment) x 100. Heat resistant spores are a
reflection of the number of spores that are not undergoing sporulation or germination.
2.19. Macrophage infections. J774A.1 mouse macrophage-like cells were infected at a
multiplicity of infection (MOI) of 10 with spores of B. anthracis strains 7702 or inhA mutant
derivatives. Infections took place for 30 minutes and were incubated at 5% CO2 at 37º C in
Difco modified Eagle’s medium (DMEM, Invitrogen, Carlsbad, CA) without the addition of
fetal bovine serum (FBS, Invitrogen, Carlsbad, CA). Spores that were not attached to, or
engulfed by, macrophages were washed out of the wells with 3 PBS rinses (Invitrogen,
Carlsbad, CA). A 30 min gentamicin treatment was then applied to kill any germinated
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spores that were extracellular to the macrophage. Gentamicin was washed from the cells
with PBS and fresh DMEM containing 5% FBS applied. Samples were taken at 0, 3, 6, and
8 h post-infection. At each time-point two cell populations were examined. The first
population consisted of all the bacilli in the infection (macrophage-associated and bacilli
that were free in the media). The second population consisted of macrophage-associated
bacilli only, and was obtained by applying a second gentamicin treatment to kill any
germinated spores in the media. After disruption of the macrophage monolayer by cell
scraping, serial dilutions were plated on LB plates without antibiotic in duplicate. Plates
were incubated overnight at 37ºC with CFUs enumerated the following day. J774A.1 mouse
macrophage-like cells were a gift from Jeffrey Actor (University of Texas, Health Science
Center, Houston).
2.20. In vivo studies. BALB/c mice were infected with a fully virulent strain (Ames) of B.
anthracis or inhA isogenic mutant via intratracheal inoculation, as previously described (97).
Briefly, inoculations were made through a small incision in the skin and spores were
injected directly into the trachea. Infection was assessed using LD50 and mean time-todeath. The LD50 (the concentration of bacteria required to kill 50% of infected animals) of
the Ames and inhA mutant strains was determined by infecting groups of 10 mice with
increasing concentrations of spores starting at 1x102. The LD50 of the Ames strain was
previously determined to be 1x103 (42). For time-to-death experiments, mice were infected
with a range of doses (low dose = 1x102 to a high dose = 1x104 ) and signs of infection were
evaluated over time. In all experiments, a negative control group of mice were generated by
inoculation with saline. Two independent experiments were carried out, with infections
initiated on different days. Experiments were performed in collaboration with Dr. C.R.
Lyons (University of New Mexico).
2.21. Minimal inhibitory concentrations. Minimal inhibitory concentrations were
determined for various antimicrobial peptides using a radial diffusion assay as previously
described (Lisanby et al 2008). Briefly, the Ames strain or inhA1/2 mutant derivative was
seeded within two layers of agarose and dilutions of the peptide of interest were imbedded
within wells bored into the agarose. Cells were grown to confluency at 37ºC, and zones of
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clearance around the peptides were measured to enable calculation of minimal inhibitory
concentrations.
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Chapter III
Modulation of the Bacillus anthracis secretome by the
Immune Inhibitor A1 protease
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3.1. Introduction
Cleavage of extracellular substrates by secreted proteases is one method by which
bacteria modulate their environment to promote survival and/or proliferation. Secreted
proteases of pathogens can inactivate essential host proteins or cleave anti-microbial host
factors (108, 156). Proteolysis of extracellular proteins by environmental bacteria can result
in peptides that serve as growth substrates or are used in cell-cell communication (1, 122).
Substrate specificity of secreted bacterial proteases can be highly variable. For
example, collagenases produced by various Clostridium species cleave a single substrate,
while the Streptococcus pyogenes SpeB protease is active against a large number of proteins
(44, 77). Three of the four classes of secreted bacterial proteases are distinguished by the
catalytic residue(s) within their active sites. These are the serine, aspartate, and cysteine
proteases (64, 123). The fourth class, the metalloproteases, require metal ions for activity.
The most common bacterial metalloproteases contain zinc in the active site and harbor a
conserved HEXXH zinc-binding sequence (64, 69).
Bacillus anthracis, a soil bacterium that is the etiological agent of anthrax, has a
complex “secretome”, or population of secreted proteins, that includes many proteases and
other degradative enzymes. Published studies employing two-dimensional electrophoresis
and mass spectrometry analyses of culture supernates have revealed large differences in the
levels of some of these enzymes when B. anthracis cells are cultured in different conditions
(2, 22, 71, 90). The most notable example is lethal factor (LF), one of the three anthrax toxin
proteins. LF, a metalloprotease, and the other (non-proteolytic) toxin proteins, protective
antigen (PA) and edema factor (EF) are induced in media containing bicarbonate and
incubated in elevated CO2 (51, 84). During growth in toxin-inducing conditions the toxin
proteins accumulate to high levels in the culture supernates but are in relatively low amounts
in cells grown under atmospheric conditions. Elevated CO2 and bicarbonate signals are
considered to be an important cue for the bacterium during infection of mammalian host
tissues. In contrast to the LF protease, chitin related proteins are abundant in culture
supernates of B. anthracis grown in air, but less abundant in supernates from cells cultured
in toxin inducing conditions (22 52), possibly reflecting a function for these degradative
enzymes B. anthracis encounters the soil environment.
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Among the most abundant proteins identified in B. anthracis culture supernatants are
the neutral protease Npr599 (also known as NprB) and the zinc metalloprotease Immune
Inhibitor A1 (InhA1) (22). Npr599 is highly abundant in supernates of cultures grown in air,
however is nearly absent when cultured with CO2/bicarbonate, whereas high levels of InhA1
are apparent in both growth conditions (22). There have been few reports describing activity
of the B. anthracis Npr599 protein. Studies of InhA1 function have centered on its potential
role as a virulence factor. InhA1 has been reported to cleave extracellular matrix proteins,
such as collagen and fibronectin (28), and to modify components of the coagulation cascade
including fibrinogen, plasminogen activator inhibitor (PAI-1) and prothrombin (26, 28, 79).
A role for InhA1 in thrombosis is apparent from ex vivo experiments demonstrating that B.
anthracis-induced clotting of human blood was delayed in a strain deleted for the InhA1
gene (79). The affects of InhA1 on coagulation would likely impact bacterial dissemination
within the host.
Here, I use a proteomic approach to demonstrate that InhA1 activity drastically alters
the composition of the B. anthracis secretome, including the anthrax toxin proteins. My
data indicate that InhA1 functions within a proteolytic regulatory cascade, modulating the
abundance of Npr599, and at least nine additional secreted proteases.

The potential

importance of this proteolytic cascade with respect to B. anthracis virulence and survival is
discussed.
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3.2. Results
3.2.1. InhA1 modulates the B. anthracis secretome. Supernate protein preparations from
stationary phase cultures of the parent strain 7702 and the isogenic inhA1-null mutant
UT345 were subjected to SDS-PAGE analysis with Coomassie staining.

Despite the

comparable growth rates and optical intensities of the cultures, the abundance of protein in
the culture supernate of the inhA1 mutant exceeded that of the supernate from the parent
strain culture, as shown in a Coomassie-stained gel (Fig. 3-1A). Proteins associated with
bands showing significantly altered densities were identified using MALDI-MS/MS.
Proteins exhibiting increased levels in the inhA1 mutant included those annotated as ABC
transporters (GBAA1191 and GBAA2041) a GroEL chaperone (GBAA0267), the S-layer
protein Sap (GBAA0885), a sulfatase (GBAA5470), and a serine protease (GBAA3660)
(118). In addition, the data indicated that the protease Npr599 (GBAA0599) had an altered
molecular weight in the parent and mutant strain samples (Fig. 3-1A), suggesting InhA1dependent processing of Npr599.
Given the large number of changes apparent in the one-dimensional electrophoretic
analysis, differential in-gel electrophoresis (DIGE) experiments were performed to facilitate
direct comparison of the parent and inhA1 mutant supernate protein profiles. Differentially
labeled protein preparations were mixed and subjected to two-dimensional SDS-PAGE (Fig.
3-2). Of the 1,340 protein spots identified using DIGE analysis, only 461 spots,
approximately one third, fluoresced yellow, indicating that the proteins were present in
equal amounts in supernates from both strains. Of the 879 remaining protein spots, 463 were
identified as less abundant in the inhA1 secretome (fluoresced green) and 416 were
identified as more abundant (fluoresced red).
I chose 96 spots for MS/MS analysis: 10 exhibiting equal abundance in the two
strains and 86 which showed a ≥9-fold change between the parent and mutant strains (17
were less abundant in the mutant and 69 were more abundant in the mutant). Of the 96 spots
tested, 51 unique protein identifications were made (Table 3-1 and Fig. 3-2). Multiple
proteins were represented as more than one spot, indicating multiple isoforms and/or sizes.
Proteases were strongly represented among the altered proteins, suggesting that a proteolytic
cascade, whereby one protease regulates the activity of a second protease, which regulates
the activity of a third protease, etc., and that the proteolytic cascade was responsible for the
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Figure 3-1. Disruption of InhA1 activity through deletion or mutation alters the
protein pattern of B. anthracis. Parent strain 7702, inhA1 null mutant UT345, and five
7702-derivatives containing point mutations within the inhA1 zinc-binding motif (H374A,
H374D/E375A, E375A, E375A/H378D, and H378A) were cultured to stationary phase.
Supernates were collected and subjected to SDS-PAGE. (A) Coomassie stained gel of
secreted proteins. Bands identified as InhA1 in the parent and the H374A and E375A mutant
strains are designated with an asterisks. Bands determined to be Npr599 are boxed. (B)
Western blot analysis with InhA1 specific antibodies.
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Figure 3-2. Deletion of inhA1 significantly alters the B. anthracis secretome. Cy3labeled supernatant proteins from parental strain 7702 and Cy5-labeled supernatant proteins
from isogenic inhA1 null mutant strain UT345 were mixed and separated using 2D-gel
analysis. Red spots represent proteins more abundant in the mutant strain. Green spots
represent proteins less abundant in the mutant strain. Yellow spots represent proteins that
are present in equal abundance in the supernatants of the parental and mutant strains.
Numbered and circled protein spots were extracted and subjected to mass spec analysis – see
Table 3-1.
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Table 3-1. Proteins identified from proteomic analysis.
gene number.

Proteins are listed by ascending

Description

Abundance in
inhA1 relative
to parent (d)

Predicted
signal
sequence (e)

GBAA0008

inosine 5 monophosphate dehydrogenase

+

-

47500503

GBAA0100

ribosomal protein L7 L12

+

-

6

47500675

GBAA0267

chaperonin GroEL

NC

-

63

47500736

GBAA0322

glutamyl tRNA Gln amidotransferase B subunit

NC

-

60, 77

47500760

GBAA0345

peroxiredoxin

+

-

27

47501025

GBAA0599

neutral protease Npr599

-

+

23, 42, 54, 55, 56

47501025

GBAA0599

neutral protease Npr599

+

+

9, 12

47501113

GBAA0685

conserved hypothetical protein

+

+

62

47501132

GBAA0703

Cytochrome aa3 quinol oxidase subunit II

+

+

Sample (a)

Gi
Accession (b)

GBAA# (c)

8

47500412

92

18, 33, 35, 38,
39, 41, 44, 47, 95

47501230

GBAA0796

conserved hypothetical protein

+

+

89

47501230

GBAA0796

conserved hypothetical protein

NC

+

81

47501516

GBAA1094

putative wall associated protein

-

+

20

47501516

GBAA1094

putative wall associated protein

+

+

7

50082984

GBAA1191

putative oligopeptide ABC transporter
binding protein

NC

+

4

47501617

GBAA1206

Oligoendopeptidase F

NC

-

13, 14

47501872

GBAA1449

peptidase M23 M37 family

+

+

15

47501934

GBAA1511

glutamate dehydrogenase NAD specific

NC

-

85

47501958

GBAA1536

putative nucleoside diphosphate kinase

-

-

65

47502136

GBAA1698

TPR glycosyl transferase domain protein

NC

-

51

47502253

GBAA1817

N acetylmuramoyl L alanine amidase family 3

-

+

87, 90

47551689

GBAA1952

putative cell wall peptidase NlpC P60 family

+

+

oligopeptide

39

47502416

GBAA1973

Transcription antiterminator LytR family

+

-

71, 75

47502674

GBAA2230

conserved hypothetical protein

+

+

30, 94

47502823

GBAA2380

alkaline serine protease subtilase family

-

+

19

47503113

GBAA2673

chitosanase

-

+

73, 78

47503268

GBAA2827

putative chitin binding protein

-

+

64

47503268

GBAA2827

putative chitin binding protein

+

+

50

47503384

GBAA2944

Polysaccharide deacetylase

+

+

89

47503408

GBAA2967

conserved domain protein

NC

+

85

47503438

GBAA2996

RocB protein

-

-

20

47503438

GBAA2996

RocB protein

+

-

31

47503629

GBAA3189

manganese ABC transporter
protein

-

+

81

47503659

GBAA3221

Bifunctional P 450 NADPH P450 reductase 1

-

-

3

47503799

GBAA3367

LPXTG motif cell wall anchor domain protein

+

+

manganese binding
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Sample (a)

Gi
Accession (b)

GBAA# (c)

Abundance in
inhA1 relative
to parent (d)

Description

Predicted
signal
sequence (e)

25, 26

47503992

GBAA3560

putative glycerophosphoryl diester phosphodiesterase

+

+

1

47504017

GBAA3584

putative microbial collagenase

-

+

45, 46

47551883

GBAA3588

putative lipoprotein

+

+

5

47504077

GBAA3645

putative oligopeptide ABC transporter
binding protein

-

+

24

47504093

GBAA3660

serine protease HtrA

+

-

91

47504174

GBAA3737

surface layer N acetylmuramoyl L alanine amidase

-

+

57, 61, 66, 84

47504174

GBAA3737

surface layer N acetylmuramoyl L alanine amidase

+

+

2

47504182

GBAA3744

transketolase

+

-

94
67, 69, 70, 72,
74, 76, 79, 83,
93, 96

47504280

GBAA3845

conserved domain protein

-

+

47504280

GBAA3845

conserved domain protein

+

+

68

47504280

GBAA3845

conserved domain protein

NC

+

58, 59

47504400

GBAA3962

ribosome recycling factor

+

-

22

47504402

GBAA3964

translation elongation factor Ts

+

-

32

47504496

GBAA4055

penicillin binding protein

-

+

65

47504630

GBAA4187

peptide deformylase

NC

-

52

47504637

GBAA4194

putative 2 3 4 5 tetrahydropyridine 2 carboxylate N
succinyltransferase

-

-

48

47504637

GBAA4194

putative 2 3 4 5 tetrahydropyridine 2 carboxylate N
succinyltransferase

+

-

16

47504830

GBAA4387

leucine dehydrogenase

NC

-

17

47504984

GBAA4539

chaperone protein DnaK

+

-

68

47505149

GBAA4702

ATP dependent protease La 1

NC

-

34, 37, 40, 43

47505198

GBAA4750

D alanyl D alanine carboxypeptidase family protein

+

+

80

47552044

GBAA4890

thiol peroxidase

+

-

36

47505336

GBAA4893

conserved hypothetical protein

+

-

88

47505769

GBAA5312

conserved hypothetical protein

+

-

10, 11, 21, 28,
29, 49

47552107

GBAA5427

putative cell wall endopeptidase NlpC P60 family

+

+

82, 86

47505946

GBAA5481

conserved domain protein

+

+

53

47506179

GBAA5696

superoxide dismutase Mn

NC

-

oligopeptide

(a) assigned in figure 3-2.
(b) Ames ancestor strain accession number
(c) Ames ancestor strain associated ORF
(d) NC – No change. +, higher in the inhA1 mutant. -, lower in the inhA1 mutant.
(e) presence (+) or absence (-) of a signal sequence predicted using the bioinformatic
program Signal P (46)
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multiple differences observed in the parent and inhA1 supernates.
Other proteins of interest that differed in the parent and inhA1 supernates included a
number of cell-envelope-associated proteins, indicating potential processing of cell surface
proteins by InhA1 or InhA1-controlled proteases. Notably, putative InhA1 substrates include
a chitinase which may be important in the soil niche of B. anthracis and enzymes associated
with peroxide reduction which may be of significance during infection of mammalian hosts.
Some of the inhA1-affected proteins are predicted to be cytosolic rather than secreted
proteins, as predicted by the presence of a signal secretion sequence. These include certain
transcriptional regulators and chaperone proteins. There is considerable overlap of the
proteins that have been identified as cytosolic in the secretome analyses of B. anthracis (2,
22). While some of these proteins may have been released from the cell as a result of cell
lysis others may have been exported through untraditional export mechanisms, resulting in
the availability of these proteins as substrates for secreted proteases.
Degradation of the anthrax toxin proteins is dependent upon inhA1. The anthrax toxin
proteins, PA, LF, and EF, represent the most-well characterized secreted virulence factors of
B. anthracis. Synthesis of these proteins is greatest when cells are cultured in media with
dissolved bicarbonate and in the presence of elevated CO2 (51, 84). To assess the effect of
inhA1 on the level of the toxin proteins in culture supernates, we cultured the parent and
inhA1 strains in toxin-inducing conditions. Supernates from exponential, transition, and
stationary phase cultures were subjected to SDS-PAGE followed by Coomassie staining and
Western blot analysis using PA-, LF-, and EF-specific antibodies (Fig. 3-3). Levels of all
three toxin proteins in the parent strain culture decreased dramatically following exponential
phase. However, the secreted toxin protein levels remained elevated throughout culture of
the inhA1 mutant strain, indicating that degradation of the toxin proteins are dependent upon
InhA1. In contrast, the toxin protein levels in supernates of the npr599-null mutant were
comparable to those of the parent, demonstrating that the Npr599 protease does not affect
toxin stability.

36

Figure 3-3. Degradation of anthrax toxin proteins is dependent upon inhA1. Parental
strain 7702, inhA1 mutant UT345, and npr599 mutant UT317, were cultured in NBY- CO2.
Secreted proteins were isolated and separated using SDS-PAGE. E, exponential phase. T,
transition phase. S, stationary phase. (A) Coomassie blue stained gel of secreted proteins.
The three toxin proteins (PA, EF, LF) are of a similar molecular weight at 85-90kDa. (B)
Western blot analysis using EF, LF, and PA-specific antibodies.
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To further explore the relationship between InhA1 and toxin degradation, InhA1 protein
levels in supernates of parent strain cultures were assessed at different growth phases. The
abundance of InhA1 increased as cultures transitioned into stationary phase, correlating with
diminished PA levels (Fig. 3-4). Taken together, the data support a model in which secretion
of InhA1 results in regulation of the anthrax toxin proteins in B. anthracis culture
supernates.
3.2.5. Capsule is unaffected in inhA1 mutants. Given the influence of InhA1 on the
stability of the secreted anthrax toxin proteins, I tested for the presence of capsule, the other
major virulence factor of B. anthracis, on cells of inhA1 and npr599 mutants. The B.
anthracis capsule is comprised of poly-D-glutamic acid polymers and is covalently linked to
the cell wall. Phase microscopy of india ink preparations of the capsulated Ames strain, an
isogenic inhA1 null mutant (UTA5), and an isogenic npr599 null mutant (UTA13) revealed
no differences in the capsulation of the cells (Fig. 3-5).
3.2.6. InhA1 activity is dependent upon the zinc-binding motif. The predicted amino
acid sequence of InhA1 includes the conserved zinc-binding motif HEXXH at amino acids
374-378 (HEYGH), which is characteristic of zinc-metalloproteases (28, 69). To determine
if this sequence is associated with InhA1 activity, inhA1 mutants encoding InhA1 alleles
with amino acid substitutions within the zinc-binding motif were constructed. As shown in
Figure 3-6, PA degradation did not occur in a culture supernate of a H374A mutant; PA
levels were comparable to those observed in the supernate of an inhA1-null strain.
Moreover, the secretome profile of the H374A mutant was comparable to that of the inhAnull strain (Fig. 3-1A). The phenotypes of additional mutants harboring amino acid
substitutions in the zinc-binding motif also displayed the inhA1-null phenotype (Fig. 3-1A).
Interestingly, the H374A and E375A InhA1 proteins migrated more slowly than the native
InhA1 protein in SDS-PAGE (Fig 3-1A and 3-1B), suggesting a possible cleavage event is
necessary for activity. N-terminal sequencing and mass spectrometry analysis of bands
reacting with anti-InhA1 antibody (Fig. 3-1B), confirmed their identity.

N-terminal

sequencing of the H374A protein confirmed cleavage of the predicted signal peptide,
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Figure 3-4. Abundance of PA in the supernatant is inversely correlated with the
abundance of InhA1. Temporal analysis of PA and InhA1 in B. anthracis culture
supernatants after culturing in NBY- CO2 as assessed using Western blot analysis with PA
and InhA1-specific antibodies. E, exponential phase. T, transition phase. S, stationary
phase.
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Figure 3-5. Capsule is unaffected by InhA1 or Npr599. Qualitative analysis of capsule
produced by the parent (Ames), inhA1 (UTA5), and npr599 (UTA13) mutant strains as
assessed using India ink exclusion assay.
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Figure 3-6. InhA1 activity is dependent on a conserved zinc binding motif. Western blot
analysis of PA abundance in the culture supernatant of parental strain 7702, inhA1 null
mutant UT345, and the H374A inhA1 zinc-binding motif mutant strain UT368. The sequence
of the zinc binding motif is shown for each strain. E, exponential phase. T, transition phase.
S, stationary phase.
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MNKKPFKVLSSIALTAVL GLSFGAGGQSVYA31, from the full length (795 amino acids)
protein. Other mutants, H374D/E375A, E375A/H378D, and H378A did not accumulate in
their culture supernates or with in the cell (Fig. 3-1), suggesting that the mutations adversely
affected stability of the protease. The instability of the H374D/E375A, E375A/H378D, and
H378A mutant strains and the lack of activity of the H374 and E375A mutant strains
suggests that the zinc-binding motif and the availability of zinc ions are important in the
regulation of InhA1.
3.2.7. Purification of InhA1. Attempts to purify InhA1 from B. anthracis Ames cured of
pXO1 and pXO2 using methods established previously (28) resulted in impure preparations
that contained the camelysin protease and the S-layer protein Sap (data not shown).
Camelysin has been implicated in degradation of InhA1 in culture supernates (Chapter IV).
To eliminate these problems, I created a B. anthracis strain deficient in secretion of these
proteins. The recombinant strain, UT357, is deleted for the camelysin gene, calY, and
carries a mutation in the secA gene which prevents Sap secretion but does not affect protease
secretion [Colin Harwood, personal communication]. InhA1 was purified from stationaryphase culture supernates of the calY secA mutant using anion exchange chromatography.
Protein purity was assessed using SDS-PAGE with Coomassie staining, Western
hybridization analysis, and mass spectrometry. Repeated purification attempts resulted in
preparations containing proteins of non-uniform size (Fig. 3-7). The major proteins with
apparent masses of 75- and 42-kD constituted bulk of the protein in the sample. These
correspond to the full length and active forms of the protein as reported previously by Chung
and coworkers (28). The re-occurring appearance of InhA1 species with specific molecular
weights suggests that InhA1 is similar to other secreted proteases in that it processed prior to
activation in a reaction that is hypothesized to be auto-proteolytic in nature (64, 157).
Results of mass spectrometry analysis of the purified protein sample indicated a pure InhA1
preparation, as all protein fragments observed corresponded to InhA1 amino acid sequences.
3.2.8. InhA1 directly cleaves the B. anthracis toxin proteins and neutral protease. Our
data from DIGE analysis of parent and inhA1-null strains reveal that inhA1 affects the
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Figure 3-7. Purification of InhA1 from B. anthracis culture supernate. Purified InhA1
protein was separated using SDS-PAGE and the gel stained with Coomassie Blue. Bands
highlighted with asterisks correspond to the molecular weights of previously identified
InhA1 protein isoforms (28).
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stability of at least eight other proteases (Table 3-1). Therefore, the global affects of InhA1
on the secretome may be attributed in part to downstream effects of one or more proteases
targeted by InhA1. To assess whether InhA1 directly or indirectly cleaves PA, EF, LF, and
Npr599 proteins we performed in vitro protease assays. Purified InhA1 was incubated with
rPA, rLF, rEF, rNpr599, or rSODA-1, a super oxide dismutase of B. anthracis utilized as a
negative control. Following incubation at 37oC, samples were subjected to Western
hybridization using antisera against the potential substrates. The toxin proteins and Npr599
were all degraded by InhA1, but susceptibilities to protease activity varied (Fig. 3-8).
Distinct PA fragments with apparent masses of 54 and 43kDa were detected immediately
upon contact with InhA1 and PA was fully degraded following extended incubation. In
contrast, processing of EF, LF, and Npr599 did not reveal abundant distinct cleavage
products, rather the majority of protein became undetectable after prolonged incubation.
Equivalent substrate:enzyme ratios and times of incubation did not result in degradation of
the SodA-1 protein.
The amino terminal sequences of the distinct PA protein fragments were determined
using amino-terminal sequencing. The amino-terminal sequences of the bands indicated in
Fig. 3-8A, NRLLNESESS, VHASFFDI, and APIALNAQDD, indicate that InhA1-mediated
cleavage of the secreted form of the PA (735-amino acid) protein occurred after residues 5,
308, and 416. It is notable that the resulting protein fragments do not correspond to the
cleavage site at residue 167 which is associated with processing required for toxin entry into
eukaryotic cells (82, 105).
The amino terminal sequence of the minor cleavage product of EF (Fig. 3-8A),
GVEKDRI, indicated InhA1-cleavage of the EF protein between residues 287 and 288. As
incubation of rLF and rNpr599 with InhA1 did not result in consistent protease reaction
products cleavage sites were not determined for these substrates. Taken together, my data do
not reveal a specific amino acid sequence associated with processing by InhA1.
Nevertheless, InhA1 directly processes the three toxin proteins and the Npr599 protease with
varying degrees of specificity.
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Figure 3-8. InhA1 directly cleaves the anthrax toxin proteins and protease Npr599.
Purified InhA1 was incubated with rPA, rLF, rEF, rNpr599, or rSodA-1. Reactions were
separated using SDS-PAGE and subjected to Western blot analysis. (A) Western analysis
using PA, LF, and EF-specific antibodies. Bands submitted for amino-terminal sequencing
are highlighted with asterisks. Amino-terminal sequences identified were VHASFFDI (PA,
54kDa band), NRLLNESESS and APIALNAQDD (PA, 43kDa band), and GVEKDRI (EF
band). (B) Western analysis using Npr599-specific antibodies. (C) Western analysis using
SodA-1 specific antibodies.
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3.3. Discussion
Using DIGE to analyze the secretome of B. anthracis it was established that InhA1,
either directly or indirectly, modified the abundance of more than half of the proteins found
in the culture supernate. While only 96 (of the 1,340 protein spots) of the most abundant
protein spots were identified, this analysis uncovered that substrates from multiple
functional categories were affected by InhA1, including putative immunomodulatory
proteins and proteins involved in nutrient acquisition.

The largest functional group

identified from the proteomic analysis was proteins with proteolytic activity, including
Npr599. While the focus of the study was to assess the contribution of InhA1 in the
modulation of the secretome, a number of cell associated proteins were also identified as
being InhA1-regulated, which implicates InhA1 in affecting how B. anthracis interacts with
its environment.
In B. anthracis, proteases constitute a considerable fraction of the secretome. InhA1
and Npr599 are the most abundant proteins in the culture supernatant (22). Purified Npr599
has some substrate overlap with InhA1 with respect to host substrates. Like InhA1, Npr599
cleaves ECM proteins collagen and fibronectin, however Npr599 is less active against
proteins of the coagulation cascade than InhA1 (28). Cleavage of the ECM components
collagen and fibronectin by B. anthracis proteases may inhibit colonization of host tissues.
Since both InhA1 and Npr599 cleave collagen and fibronectin it is unclear whether B.
anthracis adherence would be modified as a consequence of Npr599 cleavage by InhA1.
Given the abundance of Npr599 in in vitro cultures, the inactivation of this protein would be
hypothesized to have significant effects on the composition of extracellular proteins, of both
host and bacterial origin.
The activity of secreted proteases is regulated post-translationally by several
processing events, first by a signal peptidase upon secretion, then often by an auto-cleavage
event that precedes activation (64, 147, 157).

However, protease activity can also be

regulated through a proteolytic cascade, allowing for the various proteases secreted by a
bacterium to regulate the activity of other proteases (134); my data suggest that such a
cascade is used by B. anthracis to regulate the timing of specific protease activity. An early
step in the putative regulatory cascade is production of the cell-envelope-associated protease
camelysin, which is implicated in degrading InhA1 in the supernatant during early stationary
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phase (see Chapter IV). As the cells progress through stationary phase InhA1 increases in
abundance (see Chapter IV). Increased InhA1 activity leads to the processing of at least
nine other proteases present in B. anthracis culture supernatants, including the direct
processing of Npr599 and LF. A possible benefit that a protease cascade may confer upon
B. anthracis is the amplification of the number of extracellular substrates susceptible to
proteolysis by active proteases. In addition, each of the proteases available for activation are
likely regulated transcriptionally in response to independent environmental or growth phase
signals, thereby amplifying the number of input signals into the regulatory cascade.
Furthermore, a protease-based regulatory mechanism would allow for the post-translational
regulation of the proteins in the secretome, regulation that may be necessary when rapid
change of protein activity is necessary. Such regulation could be important in response to
changing signals or tissue type as the cell disseminates through the host. The presence of a
proteolytic regulatory cascade is not without precedent; such a phenomenon has been
described in Staphylococcus aureus for the regulation of extracellular proteases SspA, SspB,
and Aur. (134).
The activity of the toxin protein PA is regulated in response to physiological
conditions in the host (89, 115). PA binds host cell receptors ANTXR1 and ANTXR2 and
subsequently forms a heptameric ring on the cell surface creating binding sites for EF and/or
LF prior to endocytosis (158).

The heptameric form of PA undergoes a change in

conformation upon acidification of the endosome, allowing for the translocation of EF and
LF into the cytosol (89, 158). In addition, PA undergoes a loss in activity due to prolonged
exposure to elevated temperatures (37ºC) (115). Here I report an additional regulatory
mechanism that results in differentiated toxin protein accumulation in response to growth
phase. InhA1 accumulates in the culture supernates during the transition and stationary
phases of growth and cleaves PA within the protease accessible unstructured loops of
domain 2 (112).

Domain 2 contains critical residues involved in anthrax toxin pore

formation and links the receptor binding activity of the C-terminal domain 4 to the EF/LF
binding sites within domain-1 (89). Cleavage of PA following resides E308 and L416 by
InhA1 would disassociate the receptor and EF/LF binding subunits and may alter the
confirmation of the protein allowing for increased protease susceptibility and degradation.
Furthermore structural analysis of PA indicates that the InhA1 cleavage sites are likely to
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only be accessible when PA is in its monomeric form (89, 112), suggestive of InhA1 acting
on PA prior to host cell binding.
Degradation of the toxin proteins by InhA1 may significantly alter virulence.
Degradation may reduce development of neutralizing antibodies against these proteins in the
infected host. Alternatively, the timing of toxin accumulation may be important during
infection, and InhA1 may facilitate this by keeping toxin protein concentration low during
certain stages of infection or in a specific tissue or cell type. Interestingly, the accumulation
of toxin in the host prior to the patient becoming septic is necessary for full dissemination
(96), indicating a need for temporal regulation of the toxin proteins. It should be noted that
the processing of toxins in the extracellular milieu is not a mechanism unique to B.
anthracis. SpeB, a protease secreted by Streptococcus pyogenes, limits the concentration of
multiple other virulence factors in a growth-phase dependent manner (107), and is
hypothesized to be important in reducing the presentation of antigens during upper
respiratory tract infection (143). In addition to limiting the abundance or activity of toxins
via degradation, proteases secreted by pathogens have also been found to activate toxins, as
in the case of the Vibrio cholerae protease HA which activates the A subunit of cholera
toxin (10). To date I have no evidence of protein activation by InhA1 cleavage.
InhA1 is responsible for the cleavage of a wide array of bacterial and host substrates;
however the protease did not alter the concentration of every protein in the culture
supernate, indicating that InhA1 does have a level of substrate specificity, albeit a limited
one. This was confirmed through my in vitro proteolytic assays using purified InhA1,
establishing that InhA1 directly cleaves the anthrax toxin proteins and Npr599, but not the
superoxide dismutase, SodA-1. The rapid cleavage of PA resulting in distinct products
indicates that proteolysis by InhA1 is specific. However, as my purified InhA1 preparation
contained multiple forms of InhA1, many of which may have been inactive, it was not
possible to determine the specific activity of the protein.

It was noted that higher

concentrations of InhA1 were necessary to degrade the toxin proteins than Npr599. The
seemingly higher affinity of InhA1 for Npr599 may highlight the importance of the protease
cascade in B. anthracis.
The vast affects on the secretome of B. anthracis attributed to InhA1, due to the
apparent low substrate cleavage specificity, suggests that the spatial and temporal regulation
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of protease activity is crucial to minimize deleterious effects due to InhA1 activity. Spatial
regulation of InhA1 activity is in part accomplished through the presence of a secretion
signal sequence at the N-terminus of the proenzyme which marks the protein for secretion
(147). In its environment the availability of metal ions may limit the activity of InhA1(102).
Temporal regulation of InhA1 activity occurs through mechanisms that include: (i)
proteolytic inactivation of InhA1 function by other secreted proteases (such as camelysin
[see Chapter IV]), and (ii) regulation at the transcript level by the SinI/R regulatory proteins
(see Chapter IV).
In addition to a potential role for InhA1 in virulence my data also predict a role for
survival in the soil. As the promoter for inhA1 is active in B. anthracis when cultured in the
soil (126), it is posited that InhA1 is available to regulate environmentally-significant
proteins. Examples of environmentally-significant proteins affected by InhA1 are chitin
associated proteins. The abundance of a chitinase and chitin-binding protein were each
found to be regulated differentially in the culture supernatant of the parent and inhA1 mutant
strains. Chitinases and chitin-binding proteins are utilized by bacteria to breakdown the
cell-wall of fungi or the chitin produced by insects in the soil (151). By modulating proteins
in the environment InhA1 may regulate nutrient acquisition and prolong survival of the
bacteria or accelerate the progression into sporulation (see Chapter V).
The modulation of the B. anthracis secretome by InhA1 may have a multitude of
downstream effects, from enhancement of cell survival to increased virulence. Here I have
shown that InhA1 can act directly or indirectly to post-translationally regulate extracellular
proteins. Modulation of toxin protein levels in vitro implicates InhA1 as a post-translational
regulator of toxin in the host, potentially directing the timing of toxin protein accumulation.
This is the first bacterial protease identified to cleave the anthrax toxin proteins. The posttranslational regulation of toxin proteins in response to growth phase adds an additional
layer of regulation to toxin production, complementing the well-established regulation of
toxin gene transcription by the pleiotropic virulence protein regulator AtxA in response to
bicarbonate and elevated CO2 (51, 84). By maintaining the abundance of proteins in the
culture supernate via a proteolytic cascade the number of proteins regulated is amplified,
providing the opportunity to fine-tune the composition of proteins in the extra-cellular
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milieu through integration of multiple independent extra-cellular signals. Signaling could be
direct, in terms of co-factors available in the environment (e.g. metal ion availability), or
indirect through a plethora of transcriptional and post-transcriptional regulatory systems.
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Chapter IV
The Bacillus anthracis sin locus
and regulation of secreted proteases
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4.1. Introduction
Bacillus species are developmental bacteria that cycle between a dormant spore state
and a metabolically active vegetative cell state. Vegetative cells can grow as planktonic cells
or in multicellular biofilms. Environmental cues affect cellular and community
morphologies via complex regulatory systems that are generally conserved throughout the
genus. One such system is the pleiotropic SinI/R regulatory pair. The sin locus (sporulation
inhibitor) was originally described in B. subtilis as a component of the sporulation cascade
(55). Subsequent studies revealed that in addition to negatively regulating several genes
involved in sporulation, SinR also regulates motility, competency, proteolysis, and biofilm
formation genes in B. subtilis (7, 24, 25, 62, 78, 83, 88, 94, 100, 152). The SinR protein
binds a conserved DNA sequence upstream of the translational start site of target genes to
either positively or negatively control transcription. SinI, encoded by a gene adjacent to
sinR, is a SinR antagonist and binds directly to the SinR protein to inhibit its activity (5). In
batch culture, SinR is expressed throughout growth, while SinI expression is limited to
stationary phase (54, 133). Thus, SinR-controlled gene expression is relieved when cultures
transition from exponential to stationary phase.
While SinI/R function and the sin regulon are well established in B. subtilis, there are
few reports concerning the SinI/R regulatory system in other Bacillus species. B. anthracis,
the etiological agent of anthrax, has a sinI/R locus, but is devoid of multiple characteristics
associated with SinI/R function in B. subtilis. Unlike B. subtilis, B. anthracis is non-motile,
does not produce naturally competent cells, and does not readily produce biofilms (14, 101,
128). Although known and potential virulence factors of B. anthracis have been shown to be
produced in a growth-phase-dependent manner, there are no reports of control of these
factors by SinI/R during growth in batch culture. One study indicates that in B.
thuringiensis, an insect pathogen closely related to B. anthracis (40, 138, 150), the SinI/R
system controls expression of the immune inhibitor A1 gene inhA1; overexpression of sinR
in B. thuringiensis results in decreased expression of inhA1, while overexpression of sinI
results in elevated inhA1 transcript levels (58). Immune inhibitor A1 is a secreted
metalloprotease that degrades insect antimicrobial peptides and enhances the ability of B.
thuringiensis to escape from macrophages (116). B. anthracis also produces an InhA1
protease that has been implicated as having a role in virulence. The B. anthracis protease
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may directly affect virulence by cleaving the host proteins von Willebrand Factor and prothrombin, proteins associated with the coagulation cascade, as well as several extracellular
matrix proteins (26-28, 79, 116). Indirectly, InhA1 may affect virulence by degrading
proteins secreted by B. anthracis, including the anthrax toxin proteins (see Chapter III).
SinI/R control of B. anthracis inhA1 gene expression has not been reported.
In work described here, the role of the SinI/R system in B. anthracis was examined
using genome-wide expression

microarray and

immunoblot

analyses

to

assess

transcriptional and post-translational regulation of SinR/I-regulated genes. I show that in
addition to homologues of some B. subtilis SinR-regulated genes, the B. anthracis SinR
negatively regulates transcription of genes adjacent to the sinI/R locus that are unique to the
B. cereus group species (B. anthracis, B. cereus, and B. thuringiensis). My data show that
InhA1 protease levels are regulated at the transcriptional level by the SinI/R system and at
the post-translational level by a second SinR-regulated protease, camelysin.
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4.2. Results
4.2.1. Comparison of sin loci. In B. subtilis, the sinI and sinR genes are adjacent to each
other on the chromosome and are cotranscribed (133). The sinI/R genes of B. anthracis are
aligned similarly and are likewise hypothesized to be co-transcribed. The amino acid
sequences of the SinR proteins are 67% identical, with conserved residues spanning the
length of the proteins. Eighteen of 20 conserved residues in the B. subtilis SinR helix-turnhelix motif are identical to those of the B. anthracis SinR, and the two non-conserved
residues represent conservative substitutions. In addition, the region of SinR that is predicted
to interact with SinI (92) is moderately conserved; 21 of 29 residues are identical in the SinR
proteins of the two species. The B. subtilis and B. anthracis SinI proteins are conserved to a
lesser degree, exhibiting 42% identity and 76% similarity throughout the middle of the
proteins, the residues of SinI that interact with SinR (92). The N- and C-termini are not
conserved.
There are notable differences between B. subtilis and B. anthracis with regard to
sequences adjacent to sinI/R (Fig. 4-1). One target of the B. subtilis SinI/R regulatory
system, the tricistronic operon comprised of yqxM, sipW, and tasA, is located immediately
downstream of the B. subtilis sin operon in the opposite orientation. The yqxM/sipW/tasA
operon is associated with biofilm formation by B. subtilis (24). The yqxM gene encodes a
lipoprotein, while sipW encodes a signal peptidase, and tasA encodes a biofilm matrix
protein. B. anthracis lacks the yqxM gene and although the tandem sipW and tasA genes are
present, they are separated from sinI/R by two open reading frames (ORFs), GBAA1289 and
GBAA1290, that are absent in B. subtilis. GBAA1289 is annotated as containing a nonsense
mutation, and is therefore considered to be a pseudo-gene. ORF1290 has been designated
calY because the ORF is predicted to encode a protein with an amino acid sequence that is
greater than 90% identical to the calY-encoded protein, camelysin, of B. cereus ((59) and
NCBI blast). B. cereus camelysin is a protease that is cell-envelope associated (59).
Sequences upstream of sinI/R also differ between B. subtilis and B. anthracis. In B.
anthracis, inhA1, encoding the freely-secreted InhA1 protease, is located upstream of sinI
and in the opposite orientation (Fig. 4-1). In B. subtilis, yqhG lies 977-bp upstream of sinI in
the same orientation; the inhA1 gene is not present. An orthologue of yqhG (GBAA4451),
which encodes a conserved hypothetical protein, is present on the chromosome of
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Figure 4-1. Schematic representation of the sin loci of B. subtilis and B. anthracis. Orfs
are represented by block arrows facing the direction of transcription. Conserved genes are
color coded.
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B. anthracis at a distant locus. Analysis of the available genome sequences of species
closely related to B. anthracis, B. cereus and B. thuringiensis, indicates that the extended sin
loci in these species match that of B. anthracis.
4.2.2. Assessment of the SinR regulon in B. anthracis. Differences in sinI/R-associated
phenotypes of B. subtilis and B. anthracis, and structural dissimilarities in the sin loci,
suggest disparities in the SinR regulons of the two species. To determine the SinR regulon
of B. anthracis genome-wide transcriptional profiling experiments were conducted
comparing the fully virulent Ames strain to an isogenic sinR-null mutant, UTA21.
Transcript levels at exponential and stationary phases of growth were compared (Fig. 4-2A).
The data identified that the expression of 41 genes differed between the parent and sinR
mutant strains. Note that for a gene to be designated as SinR-regulated in my study it
required a two-fold or greater difference in regulation between the parent and sinR mutant
strain as assessed by three independent data analysis programs (Tables 4-1 and 4-2; see
chapter 2 section 5). Regulation by SinR was growth phase-dependent in all cases except
GBAA1287

(sipW),

GBAA1288

(tasA),

GBAA1290

(calY),

and

GBAA1075

(exonuclease/exonuclease phosphotase) (Fig. 4-2A, and Tables 4-1 and 4-2). All genes that
displayed differential regulation during exponential growth were negatively regulated by
SinR.
The most highly regulated genes were located within the greater sin locus. The calY,
sipW and tasA gene transcript levels were elevated 140-, 50-, and 58-fold respectively, in the
sinR mutant strain indicating negative regulation by SinR. Note that probes representing
gene GBAA1289, annotated as a pseudo-gene, were not represented in the array. In contrast
to the genes 3’ of sinI/R, expression of the upstream gene inhA1 was elevated only 2.9-fold
in the sinR mutant. Moreover, the difference in inhA1 expression was only observed using
RNA from exponential phase cultures, unlike the differences in calY, sipW and tasA
expression which were apparent at exponential and stationary phases (Tables 4-1 and 4-2).
The three most highly sinR-regulated genes outside of the expanded sin locus, GBAA1075
(exonuclease/exonuclease phosphotase), GBAA3645 (oligopeptide-binding protein oppA),
and GBAA5262 (hypothetical exported repetitive protein), were negatively regulated 5-, 6-,
and 8-fold, respectively (Tables 4-1 and 4-2).
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Figure 4-2. SinR-controlled transcriptome of B. anthracis. (A.) Scatter plot of ORFs
differentially regulated in sinR mutant strain (UTA21) relative to the parent strain (Ames) as
determined using expression microarray analysis. Data presented as log2 fold-change. The
color of the gene in the schematic below the scatter plot corresponds to the data point.
Below the schematic are the average growth of the parent (Ames) and sinR mutant strain
(UTA21). +/- standard deviation are shown. Arrows highlight the two time points analyzed
using expression microarray analysis. (B.) sinR-regulated genes during exponential growth
phase grouped by annotated function. (C.) sinR-regulated genes during stationary growth
phase grouped by annotated function.
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Table 4-1. SinR-regulated genes in B. anthracis during the exponential phase of growth.
Gene (a)

Annotation (b)

GBAA0031

GBAA1287

Methyltransferase (EC 2.1.1.-)
Hypothetical protein with endo
excinuclease domain
Transcriptional activator NprR
Oligopeptide-binding protein
oppA
RNA polymerase sigma-B
factor
Endonuclease Exonuclease
phosphatase family protein
Hypothetical protein
yajQ
Hypothetical protein
Hypothetical protein
Signal peptidase I (EC
3.4.21.89) sipW

GBAA1288

tasA

GBAA0032
GBAA0597
GBAA0908
GBAA0992
GBAA1075
GBAA1095
GBAA1166
GBAA1278
GBAA1284

d-chip
foldchange

Excel
foldchange

2.49

2.21

2.51

2.49
3.58

Array
star foldchange

Ba consensus (c)

Bs
homologue (d)

GTTATAA (-38)

N/A

GTTATAA (-50)
GTTATAT (-91)

sipW

2.48

2.4

2.15

2.18

2.21

7.99

4.77
2.1

2.25
2.11
2.26

5
2.89
2.28
2.1
2.15

3.8

50

7.55

9.5

58.82

11.98

tasA

GBAA1290

calY

63.89

142.86

121.49

ATTCTCT (-63)
GTTATAT (-69)
GTTATAA (-120)

GBAA1292

sinR

-28.34

-48.43

-21.8

GTTCTTT (-76)

sinR

GBAA1295

inhA1
Cell division initiation protein
DivIVA
Hypothetical protein
Oligopeptide-binding protein
oppA
Hypothetical protein
Zn-dependent hydrolase
Hypothetical cytosolic protein
UvrC-like protein
Hypothetical protein

1.99

2.92

2.17

GTTATAA (-66)*
GTTATAA (-77)*

N/A

2.33

3.08
2.98

2.15

GBAA1583
GBAA1959
GBAA2041
GBAA2199
GBAA2399
GBAA2525
GBAA3140
GBAA3146

GBAA3305
GBAA3645
GBAA3647
GBAA3829
GBAA3830
GBAA3845
GBAA4162

Transcriptional repressor
pagR-like
Oligopeptide-binding protein
oppA
Transcriptional regulator, LytR
family
Phage transcriptional regulator,
Cro CI family
Phage-related protein
SH3 domain protein 3D
domain protein
GTPase

2.14
4.25
2.63
2.2

2.65
3.64
2.85
3.14
3.95
2.59

2.32

2.21

3.27

3.22

2.04

5.87

5.95

3.52

2.65

2.04
5.68
3.56

3.73
2.08

N/A

GTTGTGT (-45)
ATTATGT (-61)
GTTATGT (-123)
ATTATAT (189)*

N/A
oppA

2.34
2.39

2.15
2.24
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GBAA4195
GBAA4197
GBAA4342
GBAA_pX01_101
GBAA_pX01_146
GBAA_pX01_199

Transcriptional regulators,
LysR family
Hypothetical protein
Hypothetical protein
Hypothetical protein
Transcriptional regulator atxA
GTP pyrophosphokinase (EC
2.7.6.5)

3.56
2.55
6.3
3.71
2.44

3.31
2.32
5.41
4
3.28

3.04

2.54

(a) Ames ancestor strain annotated ORF
(b) Ames ancestor strain annotated description
(c) Putative B. anthracis SinR binding site of SinR-regulated genes (nucleotides upstream of
the ATG). The asterisks indicate an inverted sequence and the number in parentheses notes
the base pairs upstream of the translational start.
(d) B. subtilis homologue of B. anthracis SinR-regulated gene
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Table 4-2. SinR-regulated genes in B. anthracis during the stationary phase of growth.
Gene (a)

Annotation (b)

d-chip
foldchange

Excel
foldchange

Array
star foldchange

Ba consensus (c)

Bs
homologue (d)

2.60
3.74

2.24
2.02

2.39
3.04

ATTCTTA (-115)
ATTCTCT (-55)

spoIIE
N/A

-3.83
-5.42
-2.90
-2.15
-3.29
-3.43
-2.85
-2.53
-2.61
-2.18
-2.21

-2.31
-2.87
-5.06
-2.78
-4.56
-5.31
-4.58
-4.78
-3.59
-6.24
-3.22

4.06
11.37
3.44
2.84

3.79

5.29
9.09
2.69

GTTATTT (-71)

N/A

GTTATAA (-31)

N/A

3.69

2.85

2.94

GTTATAA (-38)

N/A

GTTATAA (-50)
GTTATAT (-91)

sipW

GBAA1075

Stage II sporulation protein E
(EC 3.1.3.16)
Hypothetical protein
Guanine-hypoxanthine
permease
Pure
purK
purB
purC
purS
purQ
Purl
purF
purM
purN
Hypothetical membrane
spanning protein
Hyptothetical protein
Hyptothetical protein
Hyptothetical protein
Endonuclease Exonuclease
phosphatase family protein

GBAA1287

Signal peptidase I (EC
3.4.21.89) sipW

10.89

16.95

19.07

GBAA1288

tasA

10.17

9.62

13.86

GBAA0061
GBAA0229
GBAA0270
GBAA0288
GBAA0289
GBAA0290
GBAA0291
GBAA0292
GBAA0293
GBAA0294
GBAA0295
GBAA0296
GBAA0297
GBAA0573
GBAA0574
GBAA0977
GBAA1020

2.05
2.06

tasA

GBAA1290

calY

4.29

4.35

8.08

ATTCTCT (-63)
GTTATAT (-69)
GTTATAA (-120)

GBAA1292

sinR

-47.78

-50.12

-27.11

GTTCTTT (-76)

sinR

4.02

ATTCTGT (106)* GTTGTAT
(-153)

xerD

2.41

GTTCTTT (-200)

N/A

GBAA1481
GBAA1530
GBAA1577
GBAA1578
GBAA1591
GBAA1592

DNA integration
recombination inversion
protein

3.40
2.54
2.25
1.83

3.76
2.02
2.26
2.21
-6.41
-5.14

GBAA2083

Stage IV sporulation protein A
Hypothetical protein
Hypothetical protein
Xpt
pbuX
Cobalt-zinc-cadmium
resistance protein czcD
Macrolide glycosyltransferase
(EC 2.4.1.-)

GBAA2152

Hypothetical protein

2.34

2.27

2.01

ATTATAT (-27)
GTTATAA (173)* GTTATAA
(-242)

GBAA2287

polar chromosome segregation

2.35

2.71

2.36

ATTCTTT (-129)

GBAA1756

N/A

-3.00
-2.38

1.98

2.21

2.10

GTTCTTT (-253)

czcD

3.20

2.39

2.29

yojK

yvcN
racA
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GBAA2521
GBAA2619
GBAA2770
GBAA2771

Response regulator aspartate
phosphatase inhibitor

GBAA2775

Hypothetical protein
Hypothetical protein
Hypothetical protein
Dihydrolipoamide
dehydrogenase (EC 1.8.1.4)
acoL
Dihydrolipoamide
acetyltransferase component
of acetoin dehydrogenase
complex (EC 2.3.1.-) acoC
Acetoin dehydrogenase E1
component beta-subunit (EC
1.2.4.-) acoC

GBAA2776

Acetoin dehydrogenase E1
component alpha-subunit (EC
1.2.4.-) acoA

GBAA2773

GBAA2774

GBAA2853

2.14

2.15

-2.03

3.14
-2.09
-1.90

2.59
-2.34
-2.24

-2.24

-2.31

-2.61

acoL

-2.24

-2.42

-3.02

acoC

-2.31

-2.53

-2.96

acoB

-2.38

-2.42

-2.30

ATTCTCA (-173)

acoA

3.29

3.04

2.64

ATTGTGT (-21)*
GTTATTT (-302)*

divIC

ATTGTGA (218)*

glnR

GTTATTT (-37)*

N/A

3.21

2.00

-1.99
3.07

-2.01

-2.02
3.20

2.48

2.76

2.95

GTTATGT (-71)*

sigE

GBAA4044

Cell division protein divIC
Fructose-bisphosphate
aldolase (EC 4.1.2.13)
Transcriptional regulator
glnR, MerR family
Hypothetical protein
RNA polymerase sigma-E
factor
Sporulation sigma-E factor
processing peptidase (EC
3.4.23.-)

2.48

2.21

2.18

spoIIGA

GBAA4202

Hypothetical protein

2.43

2.42

2.36

ATTATGT (-101)
ATTCTTT (-17)*
ATTGTTA (-54)
GTTGTAA (-100)

N/A

GBAA4222
GBAA4342

Hypothetical cytosolic protein
Hypothetical protein
Stage III sporulation protein
AH
Stage III sporulation protein
AG
Stage III sporulation protein
AF

2.40
2.46

2.74
2.31

2.58
2.64

ATTCTTT (-69)
GTTCTGT (-197)

N/A
N/A

2.92

2.02

2.55

3.30

2.67

2.78

GBAA2982
GBAA3834
GBAA3844
GBAA4043

GBAA4410
GBAA4411
GBAA4412
GBAA4572
GBAA4657
GBAA4712
GBAA5210
GBAA5262
GBAA5523
GBAA5524
GBAA5633
GBAA5640
GBAA_pX02_0017

GTP pyrophosphokinase (EC
2.7.6.5)
Hypothetical membrane
spanning protein
Hypothetical protein
Hypothetical protein
Hypothetical exported
repetitive protein
Hypothetical protein
SpoIIQ
Prespore specific
transcriptional activator rsfA
Spore cortex lytic enzyme
cwlJ
Hypothetical protein

2.03

2.40

2.37

2.47

-2.07
-2.57
-2.33

-2.21

9.65
2.36

8.00
2.42
-2.28

6.53
2.40
-2.06

2.42

2.56

2.48

-4.04

2.08
-2.75

2.10
-2.29

spoIIIAH
spoIIIAG
GTTATTA (-52)*
GTTGTTT (-161)*

-2.20
-2.01
ATTGTAT (-52)
ATTATAT (-32)*

N/A
N/A

ATTGTTA (-70)
ATTGTAA (-131)

rsfA

N/A
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GBAA_pX02_0019
GBAA_pX02_0020
GBAA_pX02_0021
GBAA_pX02_0023
GBAA_pX02_0024
GBAA_pX02_0025

Hypothetical protein
Hypothetical protein
Hypothetical protein
Putative Type IV secretion
system component
Hypothetical protein
Hypothetical protein

GBAA_pX02_0026

Hypothetical protein

-4.57
-3.95
-4.49

-3.02
-3.00
-3.01

-3.34
-2.18
-2.42

N/A
N/A
N/A

-3.94

-3.35
-2.48
-4.78

-2.52
-2.15
-2.21

N/A
N/A
N/A

-1.85

-2.13

-3.66

GTTGTTT (-24)*
ATTCTTT (-87)*

N/A

(a) Ames ancestor strain annotated ORF
(b) Ames ancestor strain annotated description
(c) Putative B. anthracis SinR binding site of SinR-regulated genes (nucleotides upstream of
the ATG). The asterisks indicate an inverted sequence and the number in parentheses notes
the base pairs upstream of the translational start.
(d) B. subtilis homologue of B. anthracis SinR-regulated gene
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The majority of SinR-regulated genes were located on the chromosome, however a
putative 26-gene operon on pX02 virulence plasmid, starting with GBAA_pX02_0028, was
positively regulated by SinR during stationary phase growth. I note that not all of the genes
of the putative operon were found in my analysis. While the genes in the operon are largely
annotated as conserved hypotheticals, GBAA_pXO2_0023 is annotated as encoding a type
IV secretion system protein (61, 118). B. subtilis does not carry homologues of the pXO2
SinR-regulated genes.
The SinR-regulated genes of B. anthracis are grouped according to annotated
function in figures 4-2B and 4-2C. Only seven genes were identified as SinR-regulated
during the exponential phase of growth, with the largest class of genes annotated as
encoding proteins with degradative properties, including the secreted protease genes inhA1
and calY, sipW, and the nuclease-encoding gene GBAA1075 (Fig. 4-2B and Table 4-1).
Additional genes regulated by SinR during exponential growth phase include a regulatory
gene (GBAA3305), and two genes that did not fall into any distinct category (the
filamentous biofilm associated gene tasA and the ABC transporter gene oppA, GBAA3645).
In contrast, 38 genes were determined to be SinR-regulated during the stationary growth
phase, with the largest class of genes annotated as conserved hypotheticals (Fig. 4-2C).
Additional classes of SinR-regulated genes during stationary phase are genes involved in
sporulation (five, including spoIIE and spoIIGA), metabolism (five), degradation (three),
and regulation (two) genes (Table 4-2).
The promoter regions of the 41 unique genes identified as being sinR-regulated in B.
anthracis were analyzed for sequence similarity to the deduced SinR consensus sequence
from B. subtilis, GTTCTYT (Tables 4-1 and 4-2; (24)). In B. subtilis the most conserved
aspect of the consensus sequence is the spacing of the thymine residues (Fig. 4-3) (24). The
promoter regions of SinR-regulated B. anthracis genes were searched for the conserved
pattern, RTTXTXW, in which R is A or G and W is A or T. B. anthracis sequences with
similarity to the B. subtilis binding site were identified and aligned using the sequence logo
program WEBLOGO (Univeristy of CA, Berkley) to determine the putative SinR-binding
motif for the SinR protein of B. anthracis (Fig. 4-3).
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Figure 4-3. Putative SinR binding motif derived from SinR-regulated genes of B.
anthracis. The putative consensus sequence for SinR binding, derived from sequences
upstream of SinR-regulated gene in B. anthracis was aligned using the Weblogo program
(University of CA, Berkley).
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4.2.3. Comparison of the SinR regulons of B. anthracis and B. subtilis. In B. subtilis, the
SinR regulon is comprised of at least 35 genes (7, 24, 25, 62, 78, 83, 88, 94, 99, 100, 152).
Eighteen of these genes were identified in a transcriptional profiling experiment comparing
sinR- to sinI-null mutants during exponential phase of growth (24). My transcriptional
profiling data indicate only limited convergence of SinR-regulated genes from B. anthracis
and B. subtilis (Fig. 4-4). Interestingly, approximately half of the genes controlled by SinR
in each species do not have homologues in the other species (e.g. 21 genes that are SinRregulated in B. anthracis have no homologue in B. subtilis). Of the 35 genes regulated by
SinR in B. subtilis, and the 41 genes regulated by SinR in B. anthracis, only four genes were
common to both regulons (tasA, sipW, spoIIE, and spoIIG). Surprisingly, 16 SinR-regulated
genes of B. subtilis have homologues in B. anthracis that did not exhibit differential
expression in my transcriptional profiling experiment. Likewise, 17 SinR-regulated genes of
B. anthracis have homologues in B. subtilis that have not been reported as SinR–controlled
in that species (Fig. 4-4). As the putative SinR-binding motif in B. anthracis is highly
similar to the B. subtilis SinR-binding consensus sequence (Fig. 4-3), it is unlikely that
variation in the binding sequence accounts for the lack of convergence of the two SinR
regulons.
4.2.4. Specific binding of rSinR to promoter DNA. To determine if B. anthracis SinR
binds specifically to promoter regions of target genes, Electrophoretic Mobility Shift Assays
(EMSAs) were performed using rSinR purified from E. coli. DNA probes corresponded to
sequences upstream of the SinR-regulated genes calY, sipW, and inhA1, and a gene
unaffected by sinR, npr599 (Tables 4-1 and 4-2). When 10nM or higher rSinR was present
in the binding reaction, the gel mobility of the calY and sipW promoter probes was retarded
compared to the free probe (Fig. 4-5). Probes representing the non-SinR-regulated npr599
promoter and the weakly (2.9-fold) regulated inhA1 promoter were not shifted, even when
the rSinR concentration was increased to 4.2µM (data not shown). The analyses indicate that
the B. anthracis SinR is a DNA-binding protein that binds specifically to the promoter
regions of the highly-regulated target genes calY and sipW. Given that inhA1 expression is
elevated in a sinR-null mutant strain, as determined from the microarray data as well as
quantitative RT-PCR (data not shown), I posit that regulation of inhA1 by SinR is either
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Figure 4-4. Comparison of the SinR regulons of B. anthracis and B. subtilis. Total SinRregulated genes are indicated (exponential and stationary growth phases) from B. anthracis
transcriptional profiling experiments (this study) and from B. subtilis literature (7, 24, 25,
62, 78, 83, 88, 94, 99, 100, 152).
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Figure 4-5. SinR specifically binds the promoters of sinR-regulated genes calY and
sipW. EMSAs were performed using 0.1nM of probe DNA and increasing concentrations of
purified rSinR protein, 0nM, 0.4nM, 2nM, 10nM, and 50nM. npr599 promoter probe was
used as a negative control.
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Indirect or the affinity of SinR for the inhA1 promoter is greatly diminished compared to
SinR affinity for the highly-regulated sipW and calY promoters.
4.2.5. sin control of secreted proteases. Regulation of genes encoding the proteases
camelysin and InhA1 by SinR is intriguing given that InhA1 has been implicated in B.
anthracis virulence, and that homologues of camelysin produced by B. cereus and B.
thuringiensis are active against host substrates (22, 23, 26-28, 59, 79, 106). Negative
regulation of inhA1 by SinR is relatively weak (2.9-fold) and InhA has been reported to be
an abundant protein in the B. anthracis secretome whereas calY is repressed 140-fold by
SinR and does not appear to be a major component of the B. anthracis secretome (22).
I asked if InhA1 and camelysin protein levels reflect the effects of SinR on inhA1
and calY transcription. The parent strain (7702) and sinR-, sinI-, and sinI/R-null mutants
were cultured and cell pellets and supernates were collected at exponential (OD600 ≈ 1.6),
transition (OD600 ≈ 3.1) and stationary (OD600 ≈ 3.1) phases of growth. Protein samples were
assessed for camelysin, InhA1, and TasA (the product of a SinR-controlled gene that is
common to B. subtilis and B. anthracis) using Western hybridization (Fig. 4-6). Consistent
with the transcriptional profiling data, the sinR mutant produced substantially higher levels
of camelysin and TasA compared to the parent strain (Fig. 4-6). Moreover, camelysin and
TasA levels in the sinI mutant were less abundant compared to the parent strain. These
results are consistent with the B. subtilis model in which SinR regulates target gene
expression and SinI inhibits SinR activity (155). Unlike the results obtained for camelysin
and TasA, InhA1 levels did not correlate with the transcriptional profiling data. Steady state
levels of InhA1 were detected in the supernate of the parent strain during the stationary
phase of growth, but surprisingly, InhA1 protein levels were decreased in the sinR mutant
and elevated in the sinI-null mutant (Fig. 4-6). These experiments were also performed using
a different strain background (Ames cured of pXO1 and pXO2) and identical results were
obtained (data not shown). Taken together the data are indicative of a gene product under
post-transcriptional regulation.
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Figure 4-6. Effects of B. anthracis sinR and sinI on Camelysin, TasA, and InhA1. The
parental strain 7702 and sinR-, sinI-, sinIR-mutnant derivatives (UT315, UT365, and
UT371, respectively) were cultured in NBY and samples were taken during exponential
phase, transition phase, and stationary phase of growth. Cell pellets were sampled to assess
camelysin and TasA, and proteins in the culture supernatant were sampled to assess InhA1.
Western hybridization experiments were performed with camelysin, TasA, and InhA1
specific antibodies.
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Further examination of InhA1 and camelysin levels during culture of the parent
strain revealed that InhA1 and camelysin levels are inversely correlated during stationary
phase. As camelysin levels decrease, InhA1 levels increase (Fig. 4-7A). To obtain a better
understanding of the relationship between camelysin and InhA1, individual isogenic
protease mutant strains were created and InhA1 and camelysin levels in the culture
supernatant and cell pellet, respectively, were assessed using Western blot analysis. As
shown in Fig. 4-7B, in early stationary phase, InhA1 levels were significantly higher in the
calY mutant strain than in the parent strain, while camelysin levels were unchanged in the
absence of inhA1. To negate the effects of sinIR-mediated control of calY on InhA1 levels,
the calY gene was expressed from an IPTG-inducible promoter in a calY-null mutant
background. Levels of InhA1 and camelysin produced in the presence of increasing
concentrations of IPTG were determined using Western blot analysis (Fig. 4-7C). Again,
camelysin and InhA1 protein levels were inversely related, as camelysin levels increased
InhA1 levels decreased. Taken together, these results indicate that InhA1 is degraded in
supernates of cells in which camelysin synthesis is derepressed.
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Figure 4-7. camelysin controls the level of InhA1 in culture supernates. (A.)
Endogenous InhA1 and camelysin protein levels are inversely related. Parental B. anthracis
strain 7702 was cultured in NBY and samples were taken every 2 hours, beginning at the
transition phase of growth. Shown are Western blots using antibodies against camelysin and
InhA1. A corresponding growth curve of 7702 is included as a reference. (B.) InhA1 is upregulated in a calY mutant strain, however camelysin levels are unaffected in an inhA1
mutant strain. Shown are Western blots of early stationary phase samples from the parent
and inhA1- and calY-mutant derivatives, UT345 and UT356, respectively, using antibodies
to InhA1 and camelysin. (C.) Levels of camelysin produced by B. anthracis inversely
correlate with InhA1 levels in the supernatant. InhA1 and camelysin levels were detected in
parent and calY mutant strains carrying empty vector (EV; pUTE973) and the calY mutant
strain carrying the IPTG inducible calY (pUTE980). Western blot analysis used antibodies
specific to InhA1 or camelysin. The abundance of calY and inhA1 relative to the parent
strain, 7702 containing EV, were determined using densitometry analysis, the data are
presented as fold-change.
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4.3. Discussion
The common physiology of Bacillus species reflects their genomic synteny and gene
sequence similarity (118, 140). Multiple metabolic and regulatory loci, studied primarily in
the archetype species B. subtilis, have functional homologues in other Bacillus species. For
these spore-forming bacteria, shared systems controlling cell development are particularly
notable (8, 15, 38, 39, 49, 93, 95, 104, 132, 160). Here I examined function of the sinIR
locus in B. anthracis. The comparable locus in B. subtilis was first characterized as part of
the extensive sporulation network (55, 137). Subsequent studies revealed that B. subtilis
SinIR plays a regulatory role in multiple growth-phase–associated phenotypes (24, 56, 62,
94, 99). Results reported here reveal that the B. anthracis sinIR locus and the associated
regulon exhibit some similarity to those of B. subtilis, but also significant differences.
The SinIR regulatory system is comprised of the DNA-binding protein SinR, that
controls transcription of target promoters, and the SinR antagonist SinI, which when bound
to SinR prevents its association with DNA (5). Given the similarity of the SinR and SinI
amino acid sequences and data generated in this study, it is likely that the molecular
mechanisms for function of the B. anthracis and B. subtilis proteins are equivalent. I have
shown that B. anthracis SinR has specific DNA-binding activity for highly SinIR-regulated
promoters, that SinIR-regulated genes of B. anthracis possess promoter DNA sequences
with similarity to the SinR recognition sequence established in B. subtilis, and that a B.
anthracis sinI-null mutant displays the expected phenotypes for SinR-controlled genes.
Differences in the SinR regulons of B. anthracis and B. subtilis appear to be
primarily due to disparities in target genes encoded by each species. Approximately one half
of the genes reported to be SinR-regulated in either B. anthracis or B. subtilis do not have
homologues in the other species. Several SinIR-regulated genes of B. subtilis are associated
with species-specific phenotypes including biofilm formation, motility, and competency (7,
62, 88, 94).

In B. subtilis, SinIR negatively controls the biofilm-associated

extrapolysaccharide genes (eps) and the biofilm structural protein gene yqxM (24). B.
anthracis, which does not readily form biofilms, is missing these sinIR-regulated genes.
Likewise, B. anthracis is non-motile and does not carry a homologue of the B. subtilis
SinIR-regulated sigD gene (88), which encodes a transcriptional regulator of B. subtilis
motility genes. Two key competency genes, comS and srf, are SinIR-regulated in B. subtilis
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(94), but absent in B. anthracis. Finally, in B. subtilis a sinR parologue, slrR, has been
demonstrated to work in tandem with SinR to regulate select targets (17, 18), however, a
slrR homologue is not apparent in B. anthracis.
In B. subtilis and B. anthracis, several genes of the SinR regulon encode degradative
enzymes, some of which are present in one species but not the other. Among these are the B.
subtilis gene aprX, encoding a serine protease (152) and the B. anthracis genes inhA1 and
calY, encoding the InhA1 and camelysin secreted metalloproteases, respectively. The inhA1
and calY genes are present in the B. cereus group members, B. anthracis, B. thuringiensis,
and B. cereus. InhA1 was first identified as a B. thuringiensis protease that promotes
survival of the bacterium in the hemolymph of infected insects (45, 136). Subsequently it
was shown that InhA1 degrades the cecropin and attacin insect antimicrobial peptides (33).
Lereclus and coworkers (116) further demonstrated a link between InhA1 and the immune
response by showing that InhA1 enhances escape of B. thuringiensis from macrophages. It is
notable that in B. thuringiensis, overexpression of sinR results in repression of inhA1
expression (58), in agreement with the B. anthracis data revealing increased inhA1
expression in a sinR-null mutant. Similar to its orthologue in B. thuringiensis, InhA1 from B.
anthracis cleaves a number of host proteins, including proteins involved in the coagulation
cascade (including von Willebrand Factor and Pro-Thrombin) as well as extracellular matrix
proteins (26-28, 79). In addition InhA1 from B. anthracis alters the abundance of over half
of proteins in the culture supernatant either directly, as in the case of the anthrax toxin
proteins, or indirectly through its activity within a proteolytic regulatory cascade (see
Chapter III).
Camelysin, the other SinR-regulated secreted protease of B. anthracis, was first
described as a casein-lytic protein of B. cereus (59). Substrates of B. cereus camelysin
include host cell matrix proteins such as collagen and actin, as well and proteins of the
coagulation cascade (52). A camelysin homologue in B. thuringiensis has been reported to
activate Cyt2Ba, a protein toxin that exhibits activity against the Dipteran order of insects
(106). Function of the B. anthracis camelysin has not been described previously.
The degree of SinR-mediated transcriptional control of the B. anthracis inhA1 and
calY genes differs considerably. The calY gene is the most highly over-expressed in the
sinR-null strain compared to the parent and SinR directly binds the gene’s promoter region;
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while inhA1 is only weakly regulated by SinR and I was unable to demonstrate binding of
SinR to the inhA1 promoter region. The weak regulation of inhA1 by SinR is puzzling
considering that the inhA1 promoter region harbors a sequence (GTTATAA) that is similar
to the SinR recognition sequence established in B. subtilis (GTTCTYT) (24) and to
sequences in the promoter regions of the highly-regulated B. anthracis genes. In B. subtilis
and B. anthracis the number of putative SinR-binding sites upstream of individual SinRregulated genes varies from one to four. SinR may have a weak affinity for the inhA1
promoter region due to the spacing or number (two) of putative binding sites. The highly
SinR-regulated promoters examined in my study contain 1-3 putative binding sites (Table 41). Alternatively, or in addition, the nucleotide mismatches in the recognition sequence may
result in the weak regulation of inhA1 by SinR. Finally, nucleotides outside of the 7bp
putative binding site may also contribute to the strength of SinR binding.
Although SinR has a relatively small affect on inhA1 transcription, it has a large
effect on InhA1 levels in culture supernates. The data suggest that increased InhA1 in
cultures of a sinI-null mutant is associated with SinR-mediated repression of calY
transcription. When B. anthracis is cultured in rich complex media, InhA1 is one of the most
abundant proteins in stationary phase culture supernates, while camelysin levels are
relatively low (22). In a sinR-null mutant, InhA1 levels are reduced dramatically and
camelysin levels are increased. Comparison of InhA1 and camelysin levels revealed an
inverse relationship between InhA1 and camelysin, with InhA1 levels increasing as
camelysin levels decrease. Moreover, when calY expression was artificially induced, a
decrease in InhA1 was observed. Taken together, my data support a model in which InhA1
is degraded by camelysin when calY gene expression is derepressed.
InhA1 is a major component of the B. anthracis secretome that appears to degrade
host and bacterial substrates with relatively little specificity (22, 26-28, 79). A system in
which InhA1 levels are controlled transcriptionally and post-translationally in response to
the growth-phase–associated activity of SinR suggests that limitation of InhA1 abundance is
beneficial in certain environments. Interestingly, in B. thuringiensis inhA1 transcription is
controlled by another growth-phase associated regulator, AbrB (58). The weak nucleotide
sequence conservation of the reported AbrB recognition site (142, 159) makes it difficult to
predict whether the inhA1 gene is similarly controlled by AbrB in B. anthracis.
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Nevertheless, involvement of AbrB in addition to SinR in InhA1 expression would provide
an interesting link between the protease and well established virulence factors of the
bacterium. In B. anthracis, AbrB controls transcription of the pleotropic virulence gene
regulator atxA (127, 142). Future studies addressing the affects of transition state regulators
such as SinIR on temporal expression of virulence genes in the context of infection and
during B. anthracis growth in mammalian hosts and in other environments will further my
understanding of target gene function.
The role established here for camelysin in the regulation of InhA1 provides evidence
for an early step in the proteolytic regulatory cascade in B. anthracis (see Chapter III).
Defining the progression of events of the regulatory cascade is necessary to obtain a
fundamental understanding of the post-translational regulation of the extracellular proteins
of B. anthracis. The amplifying nature of a regulatory cascade provides the possibility that
regulation by one of the cascade proteases has implications on processes from bacterial
development to virulence.
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Chapter V
Characterization of the growth and virulence of an
inhA-null strain of B. anthracis
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5.1. Introduction
B. anthracis is a spore forming organism and the causative agent of anthrax. Three
forms of human anthrax infection have been described, each of which is characterized by the
route of infection, cutaneous (the most common), inhalational (highest lethality rate), and
gastrointestinal (139). In each case the infectious form of B. anthracis is the spore. Upon
exposure to nutrients in the host the spore germinates and the vegetative form of B.
anthracis spreads the disease either locally or systemically (139). While cutaneous anthrax
infections occur at higher frequency it is the inhalation form of disease that draws the most
attention, in part due to the greater lethality rate associated with inhalational anthrax
infections. The working model for the progression of inhalational anthrax can be broken
down into the following stages (Fig. 1-1): association of the spore with a phagocyte, spore
germination, dissemination of vegetative cells, and the production of virulence factors (19).
Without rapid treatment with antibiotics dissemination of the organism commonly results in
sepsis, meningoencephalitis, and death (57).

It remains contentious whether the spore

germinates within the lung, after phagocyte uptake, or upon transport to the regional lymph
nodes. An additional dissemination route is emerging as a secondary or alternative to the
phagocyte-based model in which spores transverse the epithelial cell membrane prior to
dissemination from the lung (125). The anthrax toxin receptors (ANTRX1 and ANTRX2),
cell-surface proteins that bind anthrax toxin protein leading to an alteration of host cell
signaling pathways induced by specific toxin activities, are expressed by macrophages as
well as epithelial cells located at each initial site of B. anthracis infection (lung, skin,
intestine) (6, 9). Thus, some spores may germinate prior to dissemination resulting in
production of toxin at the initial infection site stimulating a change in host cell signaling.
The cellular innate immune response to inhalational anthrax infection includes
important roles for dendritic cells and neutrophils, however macrophage are thought to be
the key immune cell of the infection process (11, 32). Mouse-derived primary macrophages
and dendritic cells infected with B. anthracis result in the release of the important proinflammatory cytokines IL-1, TNF-α, and IL-8 (11, 29, 113). Furthermore, mice chemically
depleted of macrophages show increased susceptibility to B. anthracis (32), emphasizing the
importance of macrophages in controlling B. anthracis infection.

Association of B.

anthracis spores with the macrophage is promoted through an interaction between the host
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cell Mac-1 integrin and the B. anthracis exosporium protein BclA, an interaction that leads
to phagocytosis of the spore (109). Pathogen-induced phagocytosis through macrophage
cell-surface integrin binding is a common mechanism of pathogen:macrophage association
(65, 75, 144), and it is possible that additional B. anthracis surface proteins may also
promote this mechanism of entry.
Throughout infection B. anthracis, and other pathogens, are exposed to the activity
of small cationic peptides, termed antimicrobial peptides (AMPs). AMPs are produced by a
variety of cell types, including neutrophils and macrophages.

Classically, AMPs are

grouped based on structure and fall into three main classes, defensins (α and β),
cathelicidins, and histanins (35, 63). Although AMPs such as β-defensin 1 (HBD-1) and the
human cathelicidin LL-37 are constitutively expressed in some cell types, the expression of
other AMPs can be up-regulated in response to pro-inflammatory cytokines (35, 146). The
primary antibacterial mechanism of AMPs is membrane permeation via pore formation (35,
148), leading to bacterial cell lysis. In addition, some AMPs have chemoattractant activity
towards immune cells, and are able to activate dendritic cells, induce granulocyte
degranulation, and modulate phagocyte activity (35, 63, 148). B. anthracis is susceptible to
LL-37 and possibly other AMPs (146).
Survival of B. anthracis in the host is in part due to the immune evasion activities of
anthrax toxin and of several secreted proteases. Studies into the activity of Lethal Factor
(LF) indicate that LF disrupts MAPK signaling pathways resulting in cell cycle disruption or
apoptosis (103).

The secreted protease Immune Inhibitor A1 (InhA1) has also been

implicated in enhancing B. anthracis virulence, through the cleavage of an array of
substrates.

In vitro, purified InhA1 processes extracellular matrix proteins, including

fibronectin and collogen, as well as proteins involved in the coagulation cascade, such as
plasmin inhibitors and prothrombin (28, 79).

InhA1 also induces the expression of

plasminogen activator inhibitor (PAI-1) in mice injected with purified InhA1 (26). This
modulation of coagulation proteins in the host results in an increase in the rate of clotting, as
demonstrated in human blood incubated with either parent or an inhA1 mutant strain (79).
The effects of InhA1 on host proteins may be particularly pertinent as InhA1 is one of the
most abundant proteins secreted by B. anthracis in laboratory media, and is immunoreactive
with the sera of infected animals (22, 23), suggestive of in vivo expression. B. anthracis
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encodes a homologue of inhA1, inhA2, whose gene product shares 67.7% amino acid
identity to InhA1. In contrast to InhA1, InhA2 has not been detected in secretome analysis
of this organism. However, InhA2 is detected by the immunesera of B. anthracis-infected
animals and therefore is likely produced in the host (53).
Here, I identify that inhA1 and inhA2 are transcribed under standard laboratory
conditions and, perhaps of greater interest with respect to B. anthracis virulence, also under
toxin-inducing conditions. The InhA proteins may function both early and late during
infection, as evident by an inhA1/inhA2-null mutant strain showing decreased association
with macrophage-like cells (an early stage of infection), and attenuated lethality in a mouse
intra-tracheal model of infection (early and late).

I also provide evidence that one

mechanism by which the InhA proteases enhance B. anthracis virulence is through
inhibition of the cathalicidin class of AMPs.
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5.2. Results
5.2.1. Homology of InhA1 and InhA2 in B. anthracis. Alignment of the predicted amino
acid sequences of InhA1 and InhA2 of B. anthracis indicate that the two proteins share high
levels of homology (Fig. 5-1). Identical regions of sequence between InhA1 and InhA2
include the conserved zinc binding motif HEXXH (Fig. 5-1), a characteristic of zinc
metalloproteases (64, 69). Despite high levels of amino acid identity the two InhA proteins
are not thought to be functionally redundant as several putative functional domains differ
between the proteins (Fig. 5-1). InhA2 but not InhA1 has a predicted lipobox at the aminoterminus of the protein indicating that InhA2 may be a lipoprotein, and as such may be
retained at the B. anthracis cell surface. In addition, while both InhA1 and InhA2 contain
putative integrin-binding motifs, InhA2 contains an arginine-glycine-aspartate (RGD) motif
while InhA1 has a conserved substitution in the motif resulting in a KGD sequence. The
RGD motif is a binding ligand of an array of distinct integrins, cell surface receptors that can
be specific to diverse eukaryotic cell types including macrophages, and binding can alter cell
signaling and induce phagocytosis (73, 74, 124, 144). The KGD motif has only been
described as a ligand for αIIbβIII integrins, an integrin specific to platelet cells (124). Thus,
the different predicted motifs present in InhA1 and InhA2 indicate that the two proteins may
have distinct functions during infection.
5.2.2. Expression analysis of the InhA proteases.

InhA1 is highly abundant in the

stationary phase secretome of B. anthracis grown in laboratory media (22). In addition,
InhA1 is present at a higher concentration in germinating spores than in dormant spores
(71). InhA2 has not been detected in in vitro secretome analyses of B. anthracis (2, 28),
however antibodies in the sera of infected hosts react with InhA2, indicating that InhA2 is
expressed in vivo (53, 87). To begin to investigate differences in expression of the two
proteins inhA1 and inhA2 transcripts levels were assessed using a quantitative RT-PCR
approach. Transcript levels were assessed during growth in nutrient rich media at 37°C, both
in air and in the presence of sodium bicarbonate with 5% CO2 (toxin-inducing conditions)
(Fig. 5-2). My data showed that inhA1 transcripts were significantly more abundant than
inhA2 transcripts under each of the conditions tested (Figure 5-2A). In addition, inhA1 was
differentially expressed when cells were grown under atmospheric and toxin-inducing
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Figure 5-1. Alignment of InhA1 and InhA2 predicted amino acid sequences. Ames
ancestor sequences aligned with the ClustalW program (31, 145). Residues of the conserved
zinc binding motif are indicated in the boxed sequence. The predicted lipobox of InhA2 is
highlighted in yellow and the integrin binding motifs are underlined. Conservation of
residues are color coded; red are identical (67.7%), green are strongly similar (16%), blue
are weakly similar (8.1%), and black are different (8.2%).
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Figure 5-2. Expression of inhA1 is dramatically higher than inhA2. Transcripts were
measured from samples taken during growth in air and under toxin-inducing conditions (5%
CO2 and sodium bicarbonate). (A.) Quantitative RT-PCR analysis of inhA transcript levels
relative to the housekeeping gene gyrB from exponential to stationary phases of growth.
(B.) Growth of B. anthracis in nutrient rich media in air and under toxin-inducing
conditions.
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conditions.

Increased transcript abundance under toxin-inducing conditions is a strong

indicator that InhA1 is expressed in the host. While inhA1 transcript levels correlate with
protein expression patterns during growth under toxin-inducing conditions (Fig. 5-2A and 44), transcription and steady state protein levels are uncoupled when cells are grown in air.
inhA1 transcript levels peak in early stationary phase of growth (T6; Fig. 5-2A), however,
InhA1 does not accumulate in the culture supernatant until late stationary phase (Fig. 4-6A),
supporting the hypothesis that InhA1 levels are regulated post-transcriptionally.
5.2.3. Characterization of inhA mutant strains. To facilitate analysis of the contribution
of InhA1 and/or InhA2 to B. anthracis virulence mutant strains lacking in one or both
proteases were created. The inhA genes were deleted using standard techniques that resulted
in replacement of the inhA genes with antibiotic resistance cassettes (see chapter 2, section
3). Mutant strain construction was verified using PCR and sequencing.
The growth of the inhA1, inhA2, and inhA1/inhA2 mutant strains was assessed in air
and under toxin-inducing conditions; each mutant was found to have comparable rates of
growth to the parent strain (data not shown). As InhA1 protein levels are elevated in the
germinating spore (71), the germination rates of the parent and inhA mutant strains were
assessed, using heat sensitivity, a characteristic of dormant spores, as a measure of
germination (154). Similar germination rates were found for each of the strains tested (data
not shown). To further assess the effects of the InhA proteins on the lifecycle of B.
anthracis the sporulation efficiency of the parent and inhA mutant strains were assessed.
While each of the mutants readily sporulated in sporulation medium (PA medium, phage
assay medium) or nutrient yeast broth (NBY), the inhA1 mutant strain exhibited a
sporulation defect in defined medium (CA medium, Casamino Acids medium) (Fig. 5-3).
The difference in sporulation is apparent in micrographs; by 16 hours of growth the parent
strain had been engulfed by the mother cell, forming light retractile sporangia (Fig. 5-3),
while the inhA1 mutant strain did not reach the same stage in sporulation until 30 hours
(data not shown).

83

Figure 5-3. InhA1 is necessary for efficient sporulation in defined media. The parent
strain (Ames cured of plasmids pXO1 and pXO2), and the inhA1-null derivative strain were
cultured in nutrient rich (NBY) and defined (CA) media for 16 h. Cell development was
assessed using microscopy and the relative presence of light-retractile spores was rated.
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Despite extensive efforts to complement the constructed inhA1 mutant strains I was
unsuccessful. The recovery of only small numbers of E. coli transformants, each of which
harbored mutations within the cloned inhA1 gene, is consistent with this gene being lethal in
E. coli. Similar cloning attempts were made using B. subtilis as a cloning host but this also
resulted in the recovery of colonies with mutated inhA1 genes. I was able to express an
exogenous copy of inhA1 in an inhA1-null strain of B. anthracis using an expression vector
(pBSmul1) (13). However, while B. anthracis cells containing this inhA1 construct were
viable, the cells had a significant growth defect (data not shown).

Therefore, the

“complemented” strain could not be used in my expression studies nor in subsequent
experiments. The inhA2 gene driven by its native promoter was easily cloned and integrated
into the chromosome of B. anthracis at the plcR locus, a non-functional gene in B. anthracis,
(generating strain UT306).
5.2.4. InhA proteases contribute to the initial association of B. anthracis with
macrophages. The contribution of InhA1 and InhA2 early in infection was examined using
a macrophage-association model of infection. J774A.1 mouse macrophage-like cells were
infected with spores of the B. anthracis parent strain 7702, inhA single mutant strains, or an
inhA1/inhA2 double mutant strain. Two separate cell populations were examined over time,
the total population and the macrophage-associated population.

The total population

consisted of all the bacteria in the infection (macrophage-associated and free bacteria), while
the macrophage-associated population consisted of only those bacilli associated with the
macrophages (intracellular and dormant spores), with macrophage-associated cells being
differentiated by their resistance to the antibiotic gentamicin.

Figure 5-4A is a

representative set of data obtained from an infection comparing the parent strain and the
inhA1/inhA2 double mutant strain. The data show that the population of macrophageassociated bacilli remains constant throughout the course of the experiment irrespective of
the presence/absence of the inhA genes. Thus, the inhA genes do not contribute to the ability
of B. anthracis to remain internalized.

This is contrary to similar experiments in B.

thuringiensis, which is able to escape from the infected macrophage when expressing inhA1
(116).

Interestingly, despite similar trends in the total and macrophage-associated

populations for each strain throughout the course of the experiment (Fig. 5-4A), a phenotype
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Figure 5-4. inhA mutant strains are attenuated in associated with mouse macrophagelike cells. (A.) The parent, 7702, and an inhA1/2-mutant derivative, UT284, were incubated
with mouse macrophage-like cells and the number of bacilli associated with the
macrophages, as well as the total number of bacilli in the well, was assessed over time.
Solid bars represent macrophage-associated bacilli and hatched bars represent the total
number of bacilli. Trends remain consistent between parent and inhA1/2 mutant strains. (B.)
Initial association of bacilli (T0) with macrophages, normalized to that observed with the
parent strain.
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consistently found at T0 was an approximate 10-fold difference in macrophage-association
of the parent strain and the inhA1/inhA2 double mutant strain (Fig. 5-4B). An analysis of
the percentage of inoculated spores that were macrophage-associated at T0 indicated that a
similar phenotype was also observed for each of the inhA single mutant strains (Fig. 5-4B).
The data indicate that both InhA1 and InhA2 contribute to B. anthracis:macrophage
association.
5.2.5. InhA1 and/or InhA2 protects against the activity of some cathelicidin
antimicrobial peptides. The InhA1 orthologue in B. thuringiensis degrades the insect
antimicrobial peptides cecropins and attacins to promote infection (33). To test whether
InhA1 and/or InhA2 play a role in the defense of B. anthracis against the cathelicidin class
of antimicrobial peptides (AMPs), the resistance of a fully virulent strain (Ames) of B.
anthracis and an inhA1/inhA2 isogenic mutant strain were assessed against LL-37 (human),
CRAMP (mouse), protogrin 1 (pig), and cecropin A (insect) AMPs using a radial diffusion
assay. From the data I infer that InhA1 and/or InhA2 promote the resistance of B. anthracis
to CRAMP and Cecropin A, but not to LL-37 or Protogrin 1 (Table 5-1). Differences in
protection afforded by the InhA proteins to various AMPs may be due to the fold of the
mature AMP and the ability of the InhA proteases to access cleavage sites within the folded
peptide. It remains to be tested whether other representative human AMPs can be cleaved
and inactivated by the InhA proteins.
5.2.6. An inhA1/inhA2 double mutant strain is attenuated in a murine inhalational
model of infection. To assess the contribution of InhA1 and/or InhA2 to B. anthracis
virulence I used an intra-tracheal mouse model of infection (97). BALB/c mice were
infected with a fully virulent strain (Ames) of B. anthracis or an inhA1/inhA2 isogenic
mutant.

Infection was assessed using LD50 and mean time-to-death.

Survival curves

identified that the inhA1/inhA2 mutant strain was significantly less virulent than the parent
strain (Fig. 5-5). While survival differences between the mice infected with the two strains
were reduced at higher inoculums, the mutant strain never-the-less was consistently
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Table 5-1. Minimal inhibitory concentrations of members of the cathalocidin class of
antimicrobial peptides against the parent and inhA1/2 (UTA7) strains using a radial diffusion
assay.
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Figure 5-5. InhA proteins contribute to B. anthracis virulence in a mouse model of
infection. Mice were infected with one of two doses of the parent (Ames; green) or the
inhA1/2 mutant strain (UTA7; red). N=10 for each strain in each experiment. Survival
curves generated using GraphPad Prism are representative of data collected from 2
experiments. Statistical significance was determined using logrank test.
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attenuated. The trend of decreased virulence in the mutant strain was also apparent from the
LD50 data (Table 5-2). The data are consistent with InhA1 and/or InhA2 contributing to the
virulence of B. anthracis.
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Table 5-2. Lethal Dose50 of the parent (Ames) and inhA1/2 (UTA7) using a mouse intratracheal model of infection, n=10 for each experiment.
Strain

Experiment 1

Experiment 2

Parent

330

560

∆inhA1 / inhA2

2243

1100
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5.3. Discussion
The progression or stages of anthrax disease coincide with the progression of
bacterial development in the host, from dormant spore in the alveolar space of the lung to
the vegetative cell actively secreting virulence factors in blood and tissue. My data indicate
that the InhA proteins may contribute to multiple stages of infection. InhA1 and InhA2
contribute to association with macrophage-like cells, an event early in infection.

By

enhancing the B. anthracis-macrophage association, the InhA proteins may advance the
efficiency of the initial dissemination from the lung, augmenting the ability of the bacterium
to cause disease. Given that B. anthracis is likely exposed to the membrane-disrupting
activity of antimicrobial peptides throughout infection, produced by epithelial, myeloid
precursors, and other cell types (63, 91, 121), the protective activity of the InhA proteins
against AMPs may contribute to bacterial survival both early and late in the infection
process. Due to the general activity attributed to InhA1 it is conceivable that InhA1 protects
against a wide array of AMPs that are produced throughout infection, the effectiveness of
which should be assessed in future experiments.
InhA1 activity has also been proposed late in infection (during dissemination) as the
protease modulates important factors of the coagulation cascade (26, 28, 79). In addition to
directly affecting virulence through interaction with host proteins InhA1 may affect
virulence through the processing of bacterial substrates. InhA1 significantly modulates the
secretome of B. anthracis, directly cleaving the anthrax toxin proteins, thereby affecting the
timing of toxin accumulation. While anthrax toxin significantly influences the ability of B.
anthracis to survive in the host (66), the affect of over expressing toxin in specific host
tissues has not been assessed and may detrimentally impact the progression of the infection.
As a member of a proteolytic cascade InhA1 affects the activity of numerous B. anthracis
proteases, including Npr599, greatly inflating the effects of InhA1 on proteins secreted by B.
anthracis. Taken together these processing events may affect multiple stages of infection.
The inhA double mutant strain is attenuated in the mouse intra-tracheal model of infection;
however the degree of influence of each of the aforementioned activities on infectivity has
not been determined. That said it is likely that the decreased association of the inhA mutant
strains with macrophages would directly impede the progression of disease and result in the
attenuated phenotype of the inhA mutant strain. The vast difference in inhA1 and inhA2
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transcript levels in vitro suggest that the attenuated phenotype in the mouse can, at least in
part, be attributed to the deletion of the inhA1. However, transcript levels have not been
assessed in vivo and given that both proteins are expressed in the host, as assessed antibodies
in the sera of infected animals (23, 53), the difference in inhA1 and inhA2 steady state
transcript levels may be reduced in the host.
InhA1, and to a lesser extent InhA2, have been implicated in numerous processes,
suggestive of roles in survival and virulence. The InhA proteins are classified as zinc
metalloproteases, however it may be more pragmatic to think of InhA1 and InhA2 as
multifunctional proteins with proteolytic activity. While the proteolytic activity of InhA1
has been clearly defined (see chapter III and (27, 28)), the presence of a putative integrin
binding motif within the primary amino acid sequence is suggestive of further protein
functions. If the KGD residues within the InhA1 sequence are surface exposed, InhA1
could bind the platelet glycoprotein IIbIIIa (αIIbβIII integrin) (124) inhibiting clot formation
and furthering the involvement of InhA1 in the coagulation cascade during the infection
process. A similar activity has been suggested for the S. pyogenes integrin-binding protease
SpeB (141).

Unlike InhA1, proteolytic activity has not been confirmed for InhA2 in B.

anthracis or other related species, however InhA2 does act synergistically with the B.
thuringiensis toxin proteins to cause virulence through an undefined mechanism (47, 48).
Here I show that a strain of B. anthracis with an inhA2 deletion is deficient in macrophageassociation. I propose that InhA2 uses the unique lipobox as well and the predicted RGD
motif to bind phagocyte integrins, such as CD11b/CD18 and induce bacterial:macrophage
association, as is the case of the filamentous hemagglutinin protein in Bordetella pertussis
(65). As multifunctional proteins, InhA1 and InhA2 appear to be important contributors to
the lifecycle of B. anthracis.
In addition to the postulated role of the InhA proteins in the host, a role for InhA1 in
survival outside of the host can be posited from the sporulation defect of the inhA1 mutant
strain in defined medium, a limiting environment. As sporulation is a survival mechanism
there are several possible scenarios that may explain the delay in sporulation of the inhA1
mutant strain and the possible role of InhA1 in sporulation. In the absence of InhA1 a toxic
substrate may build in abundance, slowing the progression into sporulation. Alternatively,
InhA1 may be degrading extraneous substrates in the environment, thereby providing for
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additional nutrients. While the posited limited nutrients in the inhA1 mutant strain would
affect the fitness of the organism, it is counterintuitive that this would delay sporulation.
Finally, cleavage by InhA1 may lead to the activation of a protein necessary for the
sporulation process.

Given the number of secreted proteins that are either directly or

indirectly altered by InhA1, including a number of transporters, metabolic enzymes, and
environmentally significant proteins (e.g. chitin associated), and that sporulation is merely
delayed and not aborted, suggests that InhA1 is the primary, but not sole protease, that is
necessary for a cleavage event that allows for progression into sporulation. An additional
role for InhA1 in the environment may be the inhibition of the architecture necessary for
biofilm formation. The soil bacterium and archetype of the Bacillus species B. subtilis
actively produces biofilms, a process that is regulated by the SinIR proteins (24, 80). In B.
anthracis inhA1 is located just upstream of sinIR and is regulated the by SinR (Chapter IV).
The expression and subsequent activity of InhA1 may partially be responsible for the limited
ability of B. anthracis to produce biofilms.

Further research into the involvement of

proteases in the B. anthracis lifecycle (spore to vegetative cell to spore) is necessary.
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Chapter VI
Discussion
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Bacteria secrete an array of proteins that enhance the virulence and/or survival of the
organism. Regulation of secreted protein abundance is key to ensure appropriate timing of
protein activity. Here I provide evidence that expression of the secreted Bacillus anthracis
protease InhA1 is regulated at both the transcriptional and post-translational levels. InhA1
accumulation in culture supernate has major effects on the composition and abundance of
other secreted proteins of B. anthracis, including each of the three anthrax toxin proteins and
the protease Npr599. The potential contribution of InhA1 to B. anthracis virulence is
indicated from the attenuated virulence of an inhA mutant strain in a mouse inhalational
model of infection.
In chapter III I assessed how InhA1, directly or indirectly, modulates the secretome
of B. anthracis. Data from a proteomic analysis indicated that InhA1 affects the abundance
of more than half of the proteins in the culture supernatant. The identities of 96 proteins
represented in the Differential in Gel Electrophoresis (DIGE) analysis were determined.
The focus of the study was on proteins affected by InhA1 activity, hence proteins that were
more abundant in the inhA1 mutant background were primarily chosen for identification.
Proteins from numerous functional classes were determined to be InhA1-regulated,
including proteins involved in peroxide reduction, chitin degradation and proteins with
proteolytic activity.
Importantly, the DIGE analysis indicates the possible existence of a proteolytic
regulatory cascade in B. anthracis, in which a given protease activates or disrupts the
activity of another protease, which in turn activates or disrupts additional proteases. This is
suggestive from the fact that the steady state protein levels of eight proteases (including
Npr599, the most abundant supernatant protein) were altered following inhA1 mutation.
InhA1 directly cleaves Npr599, as determined using in vitro protease cleavage assays with
purified proteases, and may also directly cleave other proteases in the cascade.

The

abundance of only two proteases was unaffected by inhA1 mutation. Thus, the data suggest
that if a proteolytic regulatory cascade is utilized by B. anthracis then InhA1 acts in a key
position within the cascade to directly or indirectly affect the abundance and/or activity of a
substantial number of proteolytic enzymes. The general activity attributed to InhA1 would
suggest that InhA1 acts late in the cascade and may abort the activity of the other proteases
in the cascade.

An alternative to the cascade model is the possibility that InhA1 acts in a
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protease complex in which the proteases act in tandem and enhance the activity of other
proteases. The models could be differentiated by assaying for an increase in the specific
activity of each protease in the absence of cleavage of the proteases using in vitro assays.
The events in either model should be further elucidated.
While InhA1 cleaves an array of substrates it does, however, retain some level of
substrate specificity. This is evident from the fact that not all proteins in the DIGE analysis
had altered abundance, as well as from in vitro protease assays using purified InhA1 protein
which showed that InhA1 does not cleave the B. anthracis superoxide dismutase protein,
SODA-1. To date the specific cleavage recognition sequence or structure has not been
determined. The broad spectrum of substrates susceptible to InhA1, as described here and in
published literature (27, 28), indicates that the protease acts as what has been termed a
“general protease”.

General proteases commonly cleave both bacterial and host /

environmental proteins.

While the InhA1-mediated cleavage of proteins during the

environmental stage of the B. anthracis lifecycle (spore to vegetative cell to spore) has yet to
be assessed, a function of such activity could be to utilize degradation products as an energy
source.
My DIGE analysis indicated that InhA1 affects the accumulation of the majority of
proteins secreted by B. anthracis when cultured under atmospheric conditions.
Subsequently, I determined that InhA1 has an equally significant role when strains were
cultured with 5% CO2 with sodium bicarbonate, conditions that are inductive for toxin
production (51, 84).

Elevated CO2 and bicarbonate signals are considered to be an

important cue for the bacterium during infection of mammalian host tissues. During the
exponential phase of growth under toxin-inducing conditions the most abundant proteins in
the culture supernatant are the anthrax toxin proteins (PA, EF, and LF), with these proteins
being depleted as the cell progresses into stationary phase (85).

The toxin protein

expression pattern is drastically altered in the inhA1 mutant strain, with the toxin proteins
remaining abundant throughout stationary phase, indicating that toxin protein degradation is
dependent upon InhA1. The timing of toxin protein degradation corresponds to InhA1
protein expression, as under toxin-inducing conditions InhA1 is found in the culture
supernatant from transition through stationary phases of growth. Results from in vitro
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protease assays showed that regulation of toxin protein abundance by InhA1 was direct, with
the protease degrading all three of the toxin proteins.
One model for toxin protein activity dictates that the monomeric form of PA binds
host cell receptors prior to cleavage by the host protease, furin, heptamer formation, and
binding of the EF and/or LF proteins (30). InhA1 preferentially cleaves after two amino
acids (308 and 416) within unstructured loops of domain 2 of PA (89, 112). Importantly,
InhA1 cleaves PA at sites separate from the furin cleavage site (82, 105). Domain 2 of PA
not only functions as a linker region between the EF/LF binding site of domain 1 and the
receptor binding site of domain 4 but also contains an unstructured loop that inserts into the
host cell membrane prior to the translocation of EF and/or LF (89). Cleavage by InhA1 may
disassociate the binding activities of PA as well as alter the confirmation of PA increasing
the susceptibility of PA to proteolytic activity. Structural analyses of PA in monomeric and
heptameric states suggest that the InhA1 cleavage sites may only be accessible in the PA
monomeric form (89, 112).
Given the dramatic alteration of the B. anthracis secretome by InhA1, the expression
of this protease was hypothesized to be tightly regulated.

In chapters IV and V the

expression and regulation of the inhA1 transcript and protein levels were discussed. The
expression of the InhA1 protein under toxin-inducing conditions correlates with transcript
levels of inhA1 which are elevated late in exponential phase and throughout stationary
phase. However, when cultured under atmospheric conditions the steady state levels of
inhA1 transcript peak as the cells enter stationary phase while protein levels are not readily
detectible until late in stationary phase. Taken together, the divergent transcript and protein
data indicate that one or more post-transcriptional regulatory event(s) regulate InhA1
expression.
Using whole-genome expression microarrays I determined that the regulatory protein
SinR regulates the transcript levels of 41 genes in B. anthracis, including negative regulation
of inhA1 transcript levels. The SinI/R regulatory proteins are conserved among Bacillus
species. In B. subtilus, SinR is a DNA-binding protein that regulates transcription of target
genes during exponential growth, while SinI is an antagonist of SinR that inhibits SinR
activity upon transition into stationary phase (5, 133). To test whether the B. anthracis SinR
protein also possessed DNA-binding activity I performed electrophoretic mobility shift
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assays. Recombinant SinR protein from B. anthracis bound specifically to the promoter
regions of two highly SinR-regulated genes (calY and sipW) but not to the promoter regions
of the negative control gene npr599 or inhA1. Thus, it appears that SinR only weakly binds
the putative binding motif upstream of inhA1 or that the regulation of inhA1 transcript levels
by SinR is indirect.
Post-transcriptionally, InhA1 is subjected to multiple mechanisms of regulation. The
activity of InhA1 is likely dependent on a processing event, an event that is hypothesized to
be auto-proteolytic in nature. In addition, InhA1 levels are inversely proportional to the
levels of the secreted protease camelysin. Similar to inhA1, the camelysin-encoding gene,
calY, is only found in the genomes of pathogenic members of the Bacillus genus, and is
regulated by SinI/R. Under atmospheric conditions camelysin is detected from the transition
to stationary phases of growth. As the cell progresses through stationary phase camelysin
levels are depleted. My data are consistent with camelysin reducing the abundance of InhA1
in the culture supernatant under atmospheric conditions, limiting detectible levels of InhA1
to a late stage of stationary phase growth. The regulation of these proteolytic enzymes has
yet to be addressed under toxin-inducing conditions.
I have presented evidence for a model in which a series of regulatory steps are used
to control the activity of InhA1 (Fig. 6-1). InhA1 is regulated transcriptionally and posttranslationally by the Sin proteins during growth under atmospheric conditions.
Transcription of the inhA1 gene is inhibited by SinR during exponential phase. Upon
transition to stationary phase, inhibition of SinR by SinI alleviates repression and inhA1 is
expressed. Following translation and secretion, InhA1 is degraded in the culture supernatant
by the SinR-regulated protease camelysin, reducing InhA1 activity in the culture
supernatant.

As the cells progress through stationary phase camelysin levels decrease

allowing for an accumulation of InhA1 and subsequent InhA1 activity.

The possible

existence of the proteolytic cascade outlined in chapter III implies that similar regulatory
mechanisms are responsible for maintaining control of other proteases secreted by B.
anthracis.
Employing multiple levels of regulation of secreted proteins is to the organism’s
advantage, enabling modulation of protein levels in response to a greater number of signals
than is achievable through a single level of regulation. The ability to post-translationally
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Figure 6-1. Model of the regulation of InhA1. SinI/R regulate expression of inhA1 and
calY, limiting gene expression to transition and stationary phases of growth. Posttranslationally, InhA1 levels in the culture supernatant are inhibited by Camelysin via
proteolysis, resulting in an accumulation of InhA1 substrates, represented here by the Toxin
proteins. As the cells progress through stationary phase camelysin levels decrease allowing
for an accumulation of InhA1 and subsequent InhA1 activity. Solid shapes signify active
proteins, while spottled shapes signify cleaved (inactive) proteins.
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regulate proteins via proteolysis provides for a level of negative regulation once a gene is
transcribed and translated, of particular importance when rapid turn-over of protein activity
is necessary. This may be the case in the host; the beneficial nature of elevated toxin levels
may be limited to certain time points in infection or at niches in the host, making InhA1
activity critical for progression of disease.
The timing of InhA1 expression, and subsequent activity, may be critical during
infection. The progression of anthrax disease can be correlated with bacterial development
and expression of virulence factors in the host. The established model for the progression of
inhalational anthrax is that once spores enter the lung they are transported to the regional
lymph nodes by phagocytes, at which point the spores germinate. The vegetative cells
disseminate throughout the host ultimately resulting in septic shock and death (139). The
characterized virulence factors produced by B. anthracis, the anthrax toxin proteins and the
poly γ-D-glutamic acid capsule, are produced during dissemination (86, 96, 98).

The

involvement of the InhA proteins in B. anthracis virulence was addressed in chapter V using
inhA1, inhA2 (a homologue of inhA1), and inhA1/inhA2 mutant strains. The inhA1/inhA2
mutant strain was attenuated in an intra-tracheal mouse model of infection, indicating that
InhA1 and/or InhA2 contribute to the infection process. As only the double mutant strain
was assessed in the mouse, the phenotype of the single mutants will need to be assessed in
future experiments to determine if the affect of the InhA proteins is due to a single protein or
if the affect is cumulative.
Given that InhA1 regulates the timing of the steady state levels of the anthrax toxin
proteins in culture supernatant, it would be interesting to assess the regulation of toxin
protein levels in vivo. Changes in PA accumulation in the blood of infected animals in
response to secreted InhA1 could be measured using an ELISA assay (98) and utilized as a
marker to monitor InhA1 activity in the host. An extension of the current study would be to
map the temporal expression of each of the proteases that constitute the putative B. anthracis
proteolytic cascade, including InhA1, in the host.

In addition to furthering our

understanding of the regulation of the secreted proteins of B. anthracis, such research would
provide insight into which, if any, of the proteases may make attractive therapeutic targets.
In addition to the putative role of InhA1 in regulating toxin protein levels in the host,
the attenuated virulence of the inhA1/inhA2 mutant strain may be due to these proteins
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contributing to an early stage of infection, the association of B. anthracis with macrophages.
As macrophages are thought to be necessary to transport spores from the site of infection to
regional lymph nodes (19), a defect in association with the macrophage may lead to
attenuated virulence. In a macrophage-association model utilizing unencapulated strains of
B. anthracis I determined that each of the single inhA mutants as well as the double mutant
exhibited a defect in association. As the capsule of B. anthracis is anti-phagocytic in nature
(81) and may mask the affects of the InhA proteins an unencapsulated strain background
was used in this study. The strong phenotype in the inhA2 mutant strain was surprising
considering that inhA2 steady state transcript levels are >1000-fold lower than that of inhA1
under toxin-inducing conditions, conditions that are thought to mimic physiologic conditions
in the host. However, these data, along with published reports that antibodies to InhA2 are
present in the sera of the infected host (53, 87), indicate that inhA2 transcript levels may be
elevated in the animal, and therefore both inhA1 and inhA2 transcript levels should be
assessed in vivo. The contribution of InhA1 and InhA2 in host-cell-association appears to be
additive. Despite the two single mutant strains having similar phenotypes, the two proteins
may not be functional homologues as assessed by differences in functional motifs predicted
from the primary amino acid sequence of the two proteins.
Bioinformatic analysis of the InhA1 and InhA2 predicted amino acid sequences
revealed that the zinc-binding motif (HEXXH) is conserved in both proteins.

InhA2

contains two putative motifs that are absent in InhA1 that may differentiate the activities of
the two proteins. InhA2 encodes a lipobox motif, a motif that promotes tethering of proteins
to the bacterial cell membrane, and an RGD or integrin binding motif, which could facilitate
interactions between B. anthracis and host cell integrins. Considering the differences in the
predicted amino acid sequences of the homologues it is conceivable that the InhA proteins
differentially contribute to B. anthracis-macrophage association.

InhA1 may process

surface exposed proteins enhancing the ability of the target protein to associate with the
macrophage or prolong bacterial survival using its demonstrated proteolytic activity against
both host and bacterial substrates ((28) and chapter III); while InhA2 may be cell surfaceassociated and as such facilitate interactions with host cell integrins to aid in host cell
association. As these activities would result in a similar phenotype in the macrophageassociation assay the proteins would appear, incorrectly, to be functionally redundant. The
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activity of the InhA proteins could be differentiated experimentally, for example by
assessing integrin binding by the two proteins.
From the data presented in this work I posit that the secreted proteases of B.
anthracis form a global regulatory mechanism used to modulate the abundance of
extracellular proteins. Given that several of these proteases are present only in the
pathogenic members of the Bacillus genus, that proteases are highly abundant in B.
anthracis cultures, and that an inhA1/inhA2 double mutant strain is attenuated in a mouse
model of infection, these data all point to the secreted proteases playing key roles in the
lifecycle of B. anthracis. By regulating extracellular protein activity B. anthracis may better
adapt to the changing environment, enhancing the survival and/or virulence of the pathogen.
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